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Abstract
The main objective of this work was to manufacture and to characterize deto-
nation nanodiamond (ND) coatings with high biocompatibility and high drug
loading capability. This was achieved via the integration of functionalized NDs
into standard coating systems. The examination of cell proliferation and cell dif-
ferentiation supported the biological assessment of the ND-enhanced coatings.
As a first step, an osteogenic peptide was covalently grafted onto oxidized
NDs. Accordingly, carboxylic acid derivatives were generated on the as-received
ND surface via an optimized heat treatment. The osteogenic peptide was teth-
ered to the oxidized ND surface using a carbodiimide crosslinking method. The
multifaceted ND preparation and disaggregation facilitated the powder handling
during the conjugation process. Moreover, antibiotics were physisorbed onto
as-received NDs to add antimicrobial properties. The correlated surface loading
of NDs was determined using various absorption spectroscopy methods such as
fluorescence and ultraviolet-visible spectroscopy.
Peptide-conjugated NDs and NDs with untreated surface chemistry have been
immobilized on different biomaterials using liquid phase deposition techniques.
Herein, polyelectrolyte multilayers (PEMs) were utilized, among others, due to
their self-organization and universal applicability for numerous substrates. In
order to assess the cell-material interactions, human fetal osteoblasts (hFOBs)
were cultured. The hFOBs exhibited a high cell proliferation, high cell density,
and sound cellular adhesion, which proves the high biocompatibility of PEMs
containing NDs.
The present study represents a novel and reliable strategy towards a public
approved composite coating. The potential of NDs as a biocompatible delivery
platform and as a coating material for biomaterials has been demonstrated. This
technology will be useful for the development and optimization of next-genera-
tion drug delivery vehicles, e.g. drug-eluting coatings, as well as for biomaterials
in general.
i

Kurzfassung
Das Hauptziel der Arbeit bestand in der Herstellung sowie der Charakterisierung
von Beschichtungen aus Detonationsnanodiamanten (ND), welche eine hohe
Biokompatibilität und eine hohe Wirkstoffbeladbarkeit aufweisen sollten. Dieses
Ziel wurde durch die Integration funktionalisierter ND in herkömmliche Be-
schichtungssysteme erreicht. Die biologische Beurteilung von den ND-verstärk-
ten Beschichtungen wurde durch Untersuchungen der Zellproliferation und der
Zelldifferenzierung untermauert.
Im ersten Schritt wurde ein Peptid mit knochenbildenden Eigenschaften ko-
valent an oxidierte ND angebunden. Mittels einer optimierten Wärmebehand-
lung wurden Carbonsäurederivate auf der ND-Oberfläche erzeugt. Anschließend
wurde das Peptid unter Verwendung eines Carbodiimid-Vernetzungsmittels an
die oxidierte ND-Oberfläche angebunden. Während des Konjugationsprozesses
erleichterte die facettenreiche ND-aufbereitung und -disaggregation die Pulver-
handhabung. Außerdem wurden Antibiotika auf den ND adsorbiert, um an-
timikrobielle Eigenschaften zu erzeugen. Die entsprechende Oberflächenbela-
dung der ND wurde unter Verwendung verschiedener absorptionsspektroskopi-
scher Ansätze wie Fluoreszenz- und UV/Vis-Spektroskopie bestimmt.
Biofunktionale und unbehandelte ND wurden über Flüssigphasenabscheidung
auf verschiedene Biomaterialien aufgebracht. Hierbei wurden unter anderem
Polyelektrolyt-Mehrschichtsysteme aufgrund ihrer Selbstorganisation und uni-
versellen Anwendbarkeit auf zahlreiche Substrate eingesetzt. Um die Zellant-
wort auf die mehrschichtigen ND zu bewerten, wurden humane Osteoblasten
(hFOB) kultiviert. Die hFOB zeigten eine hohe Zellproliferation, eine hohe
Zelldichte und eine hohe Zelladhäsion, was die hohe Biokompatibilität von
mehrschichtigen ND belegt.
Die vorliegende Arbeit stellt eine neuartige und zuverlässige Strategie für
eine allgemein anerkannte Verbundbeschichtung dar. Das Potenzial von ND als
biokompatible Medikamententräger und als Beschichtungsmaterial für Bioma-
terialien konnte aufgezeigt werden. Die dargestellte Technologie kann für die
Entwicklung und Optimierung von Medikamententrägern der nächsten Genera-
tion, z. B. in arzneimittelfreisetzenden Beschichtungen, sowie für Biomaterialien
im Allgemeinen verwendet werden.
iii
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1 Introduction and Objectives
The high pace of population aging around the world has a tremendous impact on
nearly all sectors of society, including labor and financial markets, the demand
for goods and services, as well as family structures and intergenerational ties
[1]. This crucial phenomenon is described in the demographic transition the-
ory. Therefore, the demographic transition is defined as the change from a tra-
ditional demographic regime with a high quasi-equilibrium (e.g. high mortality
and high fertility) to a modern demographic regime with a low quasi-equilibrium.
This process is usually accompanied by profound socioeconomic transformations
as well as a shift from rural to an urban lifestyle [2]. The global demographic
transition began around 1800 in Europe with decreasing mortality followed by
decreasing fertility, trends which spread around the world and continue in this
century. At the aggregate level, population size greatly increased, growth accel-
erated and declined with many countries now shrinking, and age distributions
predictably moved from young to old [3]. Although life expectancy at birth
incorporates information on mortality but not morbidity, it is the most com-
mon indicator of overall population health. Among the most notable human
achievements ever is the fact that life expectancy, which hovered in the vicinity
of 30 years throughout most of human history, has risen continuously by more
than two decades since 1950 for the world as a whole. In the more developed
regions, the increase was from 65 to 78; in the less developed regions, life ex-
pectancy raised from 41 to 67 [4]. According to the United Nations, the world’s
population is projected to grow from 7.7 billion in 2019 to 8.5 billion in 2030
(10% increase), and further to 9.7 billion in 2050 (26%). By 2050, one in six
people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%).
In Europe and Northern America, even one in four persons could be aged 65 or
over [5].
Past research has focused more on the quantity of life, but the resultant
life extension, without reducing aging, has increased the extent of aging and
age-related disease, plus pension, and social and medical costs, in an unsus-
tainable way. Generally, increased life expectancy has raised the risk of disease,
disability, dementia, and advanced aging prior to death [6]. As life expectancy
is increasing, the absolute number of older persons at risk of hip fracture is
likewise expected to increase. Furthermore, the problem of osteoporosis is an-
ticipated to grow and a rising burden on society in the foreseeable future [7].
Osteoporosis represents a major public health problem because of its association
with low-energy trauma or fragility fractures. Hip fracture has been recognized
as the most serious consequence of osteoporosis because of its complications,
which include chronic pain, disability, diminished quality of life, and premature
death [8]. With rising life expectancy throughout the globe, it is estimated that
the incidence of hip fracture will rise from 1.66 million in 1990 to 6.26 million
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by 2050 [9]. Accordingly, the European Union aims to ensure, among other
things, healthy lives and promote well-being for all at all ages within the 2030
Agenda for Sustainable Development [10].
On the one hand, the previously mentioned social transition puts a high bur-
den on global healthcare systems. On the other hand, it defines the demand for
healthcare innovations. Accordingly, the global health care spending is expected
to increase at an annual rate of 5.4% in 2017-2022, from USD 7.724 trillion to
USD 10.059 trillion. Besides, the global market for nanotechnology used in
medical applications is estimated to grow at a compound annual growth rate
(CAGR) of 14.0% from 2017-2022, and should reach USD 293.1 billion by 2022
from USD 151.9 billion in 2017 [11, 12]. At the same time, the biomaterials
market is projected to reach USD 207 billion by 2024 from USD 105 billion in
2019, at a CAGR of 14.5% between 2019 and 2024. In that connection, the
metallic biomaterials segment dominated the market in 2018. The dominant
share of this segment is primarily attributed to the broad usage of metals in the
manufacturing of medical devices used in cardiovascular, dental, and orthopedic
applications [13].
Among the metallic biomaterials, titanium is often the material of choice
due to a favorable combination of biocompatibility, corrosion resistance, tensile
strength, elastic modulus, and relatively low weight and density when com-
pared to conventional steel and cobalt-chrome alloys [14]. However, titanium
and its alloys cannot meet all of the clinical requirements. The rate and quality
of osseointegration of implants are strongly related to their surface properties.
The implant surface quality is subdivided into three categories: mechanical, to-
pographical, and physicochemical properties. These characteristics are related
and by altering any of these groups, the others will be affected. Altering the
mechanical properties within the physiological range is hard to achieve for tita-
nium, and therefore chemistry and topography are the main focus [15]. Surface
composition, hydrophilicity, and roughness are parameters that play a signifi-
cant role in implant-tissue interactions and osseointegration [16]. In order to
improve the biological, chemical, and mechanical properties of implant materi-
als, surface modification is performed, covering various techniques and coating
materials [17].
Nanoparticles as materials for drug-eluting coatings and in tissue engineering
applications describe a promising pathway to advance the future of regenerative
medicine and biomaterials in general. Such nanoparticle systems are advanta-
geous due to their low toxicity, scalable contrasting agent properties, tailorable
characteristics, targeted/stimuli-response delivery potential, and precise control
over behavior via external stimuli [18]. Disadvantages are high manufacturing
costs, nonspecific imaging in cells, high contrast and number of nanoparticles
while avoiding toxic effects, and the interactions with plasma proteins in vivo
may alter the nanoparticle’s properties [19]. In conclusion, while nanoparti-
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cles have demonstrated promising potential in tissue engineering applications
such as enhancement of biological, mechanical and electrical properties, an-
timicrobial effects, gene delivery and construction of engineered tissues, many
challenges still lie ahead to introduce them into widespread clinical applica-
tions [20]. Nevertheless, nanotechnology-based developments are key factors
in current healthcare products. The existing applications of nanomaterials in re-
generative medicine cover various fields, such as drug delivery systems, imaging
and diagnosis, disease therapy, and tissue engineering [21,22].
Within the broad spectrum of nanoparticles used in regenerative medicine
and biomaterial research, some of the most crucial representatives are detona-
tion nanodiamonds (NDs). NDs are discussed, among other applications, as
nanocarriers, bioimaging agents, and additives for nanocomposites due to their
superior chemical and mechanical properties [23]. The increasing interest of
the scientific community in the ND research leads to a high growth rate in pub-
lications related to NDs. Figure 1.1 (a) displays the absolute growth rate of all
publications in the broader research field of materials science and the more spe-
cific subfields of graphene, nanotube, quantum dot, and nanodiamond research.
The general growth rate of publications in the field of materials science is 1.65
and refers to the average increase in published research articles from 2009 and
2018. The highest growth rate was obtained in the subfield of graphene with
14.10, which is based on its promising combination of electrical and mechanical
properties [24, 25]. The growth rate of publications related to nanodiamond
research is the second-highest with 2.31 among the presented subfields and
demonstrates an increasing tendency. On the contrary, the nanotube research
possesses the lowest growth rate of 1.59 and shows a stagnant development.
Figure 1.1 (b) exhibits the total number of publications for the respective year
of publication. Despite the high growth rate of publications related to nanodia-
mond research, the total number of publications remains at a low level with a
maximum of 125 publications in 2018, while the total number of publications
concerning graphene research reached 10 000 by 2016. However, the nanodia-
mond research is a promising field with a bright future and immense capacities
for the ongoing development in various scientific discoveries and industrial ap-
plications.
1.1 Scope of the Thesis
Despite the extensive body of literature that has developed in the last two
decades, ND systems provide many challenges of scientific, technological, and
industrial interest. While NDs have been widely studied for their photolumines-
cent properties as well as their mechanical properties, no detailed investigation
of their application in surface engineering were reported, regardless of the fact
that NDs display excellent drug delivery properties with various functional sur-
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Figure 1.1: (a) The absolute growth rate of publications related to the corresponding research field in the
years 2009 and 2018. (b) Total number of publications per year. Data collected from Web of Science™ [26].
1.1 Scope of the Thesis 5
face groups (see Section 2.4). Important aspects of the ND research that require
detailed studies include, but are not limited to:
(a) Functionalization of NDs. NDs are an outstanding material with supe-
rior physical properties to develop next-generation drug delivery vehi-
cles and to tether various biomolecules. Their functionalization leads
to a synergetic effect between the core properties of NDs and the uti-
lized biomolecules, wherein their functionalities and characteristics are
merged. Physisorption or chemisorption of biomolecules onto NDs are
versatile surface modification pathways, which are either based on elec-
trostatic or covalent interactions. In order to introduce osteogenic or
antimicrobial properties, relevant small biomolecules and peptides can
accordingly be grafted onto NDs. The successful surface modification
of NDs has to be assessed using adsorption spectroscopy techniques,
such as infrared, ultraviolet-visible, and mass spectroscopy, to ensure a
specific cell-material interaction. Prior to the functionalization of NDs,
the initial ND surface chemistry can be altered via different oxidation
methods, whereby the final oxidation pathway influences the number
of oxygen-containing surface groups. The structure of the ND core has
to be maintained during the oxidation process. Consequently, the num-
ber of functional surface groups will affect the surface loading of NDs
with biomolecules and their ultimate application.
(b) Surface engineering of biomaterials. The surface mainly determines
the cellular response to biomaterials and the engineering of these sur-
faces offers ample opportunities to establish a specific cell-material in-
teraction. Accordingly, numerous surface engineering approaches en-
compass a broad spectrum of techniques, where the liquid phase de-
position is favorable due to its scalability and applicability on differ-
ent materials under ambient conditions. Polyelectrolyte multilayers,
among other liquid phase deposition techniques, are suitable to con-
trol the final yield and roughness of immobilized NDs. The optimiza-
tion of polyelectrolyte multilayers containing biofunctional NDs leads
to drug-eluting coatings with high biocompatibility and adaptable re-
lease mechanisms. The exposed NDs provide anchorage to the cells
and are able to carry different biomolecules. In order to optimize the
uptake of NDs into cells as well as their clearance, the determination
of the ND agglomerate size distribution and the correlated zeta po-
tential is essential. The immobilization of NDs on macroscopic sur-
faces has several advantages compared to dense diamond coatings,
such as non-susceptibility to cracks and utilization of inexpensive de-
vices. Moreover, non-covalent immobilized NDs are cleavable, which
results in a local and sustainable release of NDs from the surface of
biomaterials.
6 1 Introduction and Objectives
(c) Cell-material interactions. The biological characterization of conju-
gated NDs is the key to predict their efficiency as drug delivery vehicles
and to address their reliability in biomedical applications. NDs tethered
to biomolecules and immobilized on biomaterials provide the opportu-
nity to generate a sustainable release of pharmaceuticals in combina-
tion with nanostructured surfaces. In order to meet the public require-
ments of medical devices and combination products, a high biocompat-
ibility of ND coatings is fundamental in this context. The topography
of immobilized NDs influences the filopodia formation of the cultured
cells and ultimately determines the cellular adhesion strength as well
as the biocompatibility of the substrate. Furthermore, NDs conjugated
to osteogenic peptides have the capability to alter the differentiation
of mesenchymal stem cells and to promote bone formation, whereas
NDs tethered to antibiotics provide sustainable antimicrobial proper-
ties. Moreover, different factors, such as surface charge and mechanical
properties, affect the cell-material interactions.
The present thesis, therefore, addresses the three fundamental aspects stated
and aims to contribute to the understanding of the ND surface properties, coat-
ing behavior, and the biological performance of biofunctional NDs. The findings
obtained in this work should help to gain an expanded knowledge in the field
of nanomaterials applied in biomedical applications and thus aid in developing
novel composite materials with improved properties based on NDs.


2 Fundamentals
The surface engineering of biomaterials using functional nanoparticles and the
related characterization of the cell-material interactions requires an interdisci-
plinary understanding of materials science, chemistry, and molecular cell biol-
ogy. Therefore, Section 2.1 gives an overview of the prevalent biomaterials. Sec-
tion 2.2 deals with the surface modification techniques and Section 2.3 describes
the influence of the biomaterial properties on cell behavior. Finally, Section 2.4
introduces detonation nanodiamonds, their applications in the field of biomedi-
cal research, functionalization pathways, and their agglomeration behavior.
2.1 Overview of Biomaterials
The field of biomaterials research increased tremendously during the last decades
as such materials enhance the quality and longevity of humankind. With a
correlated increase in medical applications, the demand for a broad range of
biomaterials is ever-increasing, and the prospects for growth in this field is lim-
itless [27]. In the year 1983, Galletti and Boretos defined biomaterials as sub-
stances that can be placed in contact with living structures in the absence of
harmful effects. Moreover, most biomaterials have close and often prolonged
contact with the living body tissues [28]. This definition changed drastically
over the years, where biomaterials provide dedicated functionalities and induce
biological responses. Nowadays, biomaterials are widely accepted as substances
that have been engineered to take a form which, alone or as part of a complex
system, are used to direct, by control of interactions with components of liv-
ing systems, the course of any therapeutic or diagnostic procedure in human or
veterinary medicine [29]. Figure 2.1 presents a brief overview of broadly used
biomedical materials. It should be noted that biologically inspired and biomolec-
ular materials, as well as materials of biological origin, are excluded from the
present overview. Metallic biomaterials have been used mainly for the fabrica-
tion of medical devices for the replacement of hard tissue such as artificial hip
joints, bone plates, and dental implants since they are very reliable from the
viewpoint of mechanical performance [38]. Metallic biomaterials possess ex-
cellent mechanical properties (high tensile strength, high fracture toughness),
and therefore long-term stability in the highly reactive environment within the
human body. However, the highly reactive environment may lead to their degra-
dation, which can in turn result in the release of undesired metallic ions [39].
Polymers are well suited for biomedical applications due to their diverse and
customizable properties [40]. Polymeric biomaterials are applied in skin, car-
tilage, bone, vascular nerve regeneration, drug delivery systems with different
routes of administration, surgical, and support materials [41]. Their principal
disadvantage lies in the development of reproducible manufacturing methods
because their structural complexity often renders modification and purification
9
10 2 Fundamentals
Polyamides
Polyolefin
Polyesters
Polytetraflu-
oroethylene
Polyurethane
Polymers
Biomedical materials
Aluminium oxides
Zirconia oxide
Silicon nitride
Calcium phosphates
Bioglass-ceramics
Vitreous carbon
CeramicsMetallic biomaterials
Stainless steel
Cobalt and its alloy
Chromium and its alloy
Titanium and its alloy
Precious metals
Magnesium alloys
Figure 2.1: Overview of materials utilized for biomedical applications. Adapted from [30–37].
difficulties. Furthermore, the mechanical characteristics (low tensile strength),
as well as the diffusive and biological properties of polymers, can be problem-
atic [42]. The most biocompatible materials belong to the group of ceramics. In
general, ceramics show high biocompatibility, high resistance to corrosion, high
resistance to compression, low electrical and thermal conductivities. On the
other hand, ceramics are brittle with low impact resistance, properties that are
difficult to reproduce, and challenging fabrication pathways [43]. In particular,
bioglass-ceramics are suitable for biomedical applications due to their bioactive
aspect to form an interfacial bond with bones or tissues [44]. Further biomedi-
cal applications of ceramics are ranging from orthopedic and dental implants to
drug delivery systems [45].
Biomaterials can be classified as biotoxic, bioinert, bioactive, or bioresorbable.
Biotoxic materials lead to atrophy, pathological change, or rejection of living
tissues. Bioinertness describes the minimization of chemical actions by the ma-
terial on living organisms. Bioactivity defines the ability of the material to take
part in the metabolism processes in a living body and bioresorbable materials
show the capability of gradual dissolution by the biosystem over time [46].
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2.2 Surface Modification Techniques of Biomaterials
The initial response of the living tissue mainly depends on the surface charac-
teristics of the biomaterials. In order to facilitate the biointegration and to influ-
ence the cell-material interactions, surface modifications are a vital approach.
The surface modification typically improves bonding strength, wear resistance,
corrosion resistance, biocompatibility, hemocompatibility, protein adsorption,
and cell adhesion [47]. Consequently, the applied coating technique consid-
erably changes the composition, structure, and morphology of the biomaterial
surface. Figure 2.2 summarizes the coating technologies of biomaterials. Phys-
ical modification techniques involve plasma coatings, ion beam implantation,
and surface patterning. Plasma-sprayed or ion beam implanted calcium phos-
phate coatings are prominent representatives among the physical surface modi-
fications [48, 49]. The similarity of calcium phosphates with the mineral phase
as present in bone and teeth facilitates their application [50].
Innovative chemical modification techniques promote, among other things,
the osseointegration of biomaterials. The most popular surface treatments of
dental implants are anodization and acid-etching, where the increase in surface
roughness, morphology, and change in surface chemistry fosters the osseoin-
tegration [51, 52]. Further chemical modifications are chemical vapor depo-
sition, self-assembled polymers, Langmuir-Blodgett films, and electrochemical
deposition with various advantages such as additional bioactive components or
enhanced mechanical and anticorrosive properties [53].
The field of biologically modified biomaterials comprises different approaches
from engineered protein coatings to combined cell therapy. It is well described
that implanted materials are immediately coated with proteins from blood and
interstitial fluids, and it is through this adsorbed layer that cells sense foreign
surfaces. Hence, it is the adsorbed protein, rather than the surface itself, to
which cells initially respond. Diverse studies using a range of materials have
demonstrated the pivotal role of the extracellular matrix proteins in cell prolif-
eration, morphology, adhesion, and cell death [54]. The extracellular matrix is
Plasma technique
Ion beam implantation
Surface pa ern
Chemical grafting
Self-assembled layers
Langmuir-Blodge 
Protein immobilization
Growth factor binding
Pre-cultivated cell culture
Surface modification methods
Biological modificationChemical modificationPhysical modification
Figure 2.2: Coating techniques of biomaterials. Adapted from [47].
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the noncellular component present within all tissues and organs [55]. The com-
ponents of the extracellular matrix are secreted by fibroblasts in most tissues
and are categorized into proteoglycans and fibrous proteins (collagen, elastin, fi-
bronectin, laminin, and vitronectin). These components give structural support
and facilitate cellular communication [56]. Under this approach, fibronectin
and vitronectin coated titanium promote the cell attachment and proliferation
of human fetal osteoblasts [57].
The delivery of growth factors and cytokines from the surface of biomaterials
is another pathway to regulate the target tissue growth, potential proliferation,
and inflammatory response. Growth factors and cytokines are biologically ac-
tive polypeptides that act to alter the growth, differentiation, and metabolism
of a target cell [58]. Historically, cytokines were associated with hematopoiesis,
endocrine function, and brain development [59]. Although the historical dis-
tinction between cytokines and growth factors was based on the biological roles
of the earliest discovered examples, there are also characteristic structural dif-
ferences in their receptors. Growth factor receptors typically have a kinase do-
main, whereas cytokine receptors do not contain a kinase domain as part of
their structure [60]. Herein, bone morphogenetic proteins, belonging to the
transforming growth factor-β superfamily, are able to modulate differentiation
and proliferation of osteoblasts and osteoclasts [61]. The name “bone morpho-
genetic protein” was formerly assigned for the unique activity of the protein to
induce heterotopic bone formation in nonskeletal tissues, such as skeletal mus-
cle and subcutaneous tissue [62]. Bone morphogenetic protein-2 (BMP-2) is
the only Food and Drug Administration (FDA) approved osteoinductive growth
factor employed in bone graft substitute [63]. However, the short half-lives of
growth factors, their relatively large size, and their potential toxicity at high sys-
temic doses suggest that conventional delivery techniques are not well suited to
their clinical administration. In order to address these limitations, more sophis-
ticated delivery systems that allow for controlled, precise, sustained, and local-
ized release of these proteins have to develop, enabling optimal doses and spa-
tial/temporal gradients in localized sites for effective tissue regeneration [64].
Accordingly, BMP-2 has been immobilized on numerous biomaterials and hybrid
materials to promote bone formation [65,66].
Combining stem cells with biomaterial scaffolds serves as a promising strat-
egy for engineering tissues for both in vitro and in vivo applications [67]. Stem
cells entrapped in hydrogels, along with growth factors, advance bone formation
[68]. The cell pre-culture period influences the in vitro mineralization. Human
mesenchymal stem cells (hMSCs) cultured on silk fibroin scaffolds were pre-
cultured for different periods to foster cell proliferation and distribution [69].
Furthermore, the approach of pre-cultivated scaffolds involves collagen-based
membranes modified with harvested autologous chondrocytes for the repair of
articular cartilage defects [70].
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2.3 Cellular Response to Tailored Biomaterials
The interaction of cells with material surfaces is of fundamental relevance and
contributes to the clinical success of biomaterials [71]. As shown in Figure 2.3,
the cell response to the chemical composition, surface chemistry, topography,
and mechanics of the substrate has comprehensively been investigated. Accord-
ingly, these properties alter cell differentiation, proliferation, adhesion, align-
ment, mechanotransduction, and migration [72].
Cell migration is defined as a highly integrated multistep process that orches-
trates embryonic morphogenesis. Furthermore, the cell migration is a prominent
component of tissue repair and immune surveillance, in which leukocytes from
the circulation migrate into the surrounding tissue to destroy invading microor-
ganisms and infected cells and to clear debris [73]. Morphogenesis describes
the cell and tissue movements that give the developing organ or organism its
shape in three dimensions [74]. Cell proliferation is defined as the cellular
growth rate. In order to assess the proliferation, the changes in nuclei acid
content are most commonly measured [75]. Cell differentiation refers to the
mechanism whereby different sorts of cells arise. Each cell type owes its specific
character to particular proteins coded by distinct genes [74]. Cell adhesion is
a process that is initiated by the attachment of cells to specific sites in adhesive
matrix proteins via cell surface receptors of the integrin family. The subsequent
reorganization of cytoskeletal elements results in cell spreading and the forma-
tion of focal adhesion [76]. Adherent cells are anchored via focal adhesions
to the extracellular matrix, while cell-cell contacts are connected via adherens
junctions. Force transmission over considerable distances and stress focusing
at these adhesion sites makes them prime candidates for mechanosensors [77].
Cells sense their physical surroundings through mechanotransduction by trans-
lating mechanical forces and deformations into biochemical signals [78]. The
conversion of mechanical signals into chemical signals or gene expression is
called mechanochemical transduction, or mechanotransduction [79].
Biochemical, topographic 
and mechanical signals
Material
Composition
Surface chemistry
Topography
Stiffness
Cell behaviour
Differentiation
Proliferation  
Adhesion 
Alignment 
Mechanotransduction
Migration
Figure 2.3: Fundamental cell-material interactions.
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Biomaterials are able to influence the previously mentioned cell mechanisms.
The composition of the biomaterial defines, among others, its cytotoxicity. Alu-
minum, vanadium, and nickel are frequently applied in metallic biomaterials
and considered to be cytotoxic at specific concentrations [80, 81]. Moreover,
abnormal content of aluminum in the human body can cause many health haz-
ards such as Alzheimer’s disease, osteomalacia, and breast cancer [82]. In the
last decade, there has been a concern about possible hypersensitivity reactions
to foreign materials implanted in the body. The most common form of metal
hypersensitivity is contact dermatitis due to nickel, which has led the Northern
European countries to regulate consumer nickel exposure [83].
As stated in Section 2.2, the surface of biomaterials plays a significant role in
the interactions between cells and materials. The surface charge of the substrate
alters, among others, the cell adhesion [84]. Osteoblasts and fibroblasts adhere
in a similar charge-dependent manner with the most eminent attachment on
positively charged surfaces followed by negatively and then neutrally charged
surfaces [85]. For surfaces with neutral groups (amide and hydroxyl groups),
the hydroxyl group grafted surface shows more vigorous cell adhesion, probably
due to specific hydrogen bonding between the surface and the polar groups of
the cell membrane [86]. Another critical property of biomaterials is their surface
wettability. Moderately hydrophilic surfaces (20-40 degree water contact angle)
promote the highest levels of cell attachment. Among the hydrophilic surfaces,
differences in charge and wettability influence cell attachment but not cell area,
shape, or cytoskeletal organization [87]. The surface wettability, the ratio and
density of the functional surface groups, as well as the kinds of applied cells
principally affects the cell adhesion [88].
The topographic modification alters different cell functions depending on its
pattern. Accordingly, anisotropic ridges and grooves influence the contact-guided
cell alignment, whereas isotropic textures owning randomly or evenly distributed
topographic features remodel the collective cell functions [89]. Controlled cel-
lular alignment plays a crucial role in the microarchitecture of many human tis-
sues, dictating their biological and mechanical functions. For example, in native
myocardial tissue, the complex organization of cardiomyocytes and fibroblasts
within the cardiac extracellular matrix is critical to the electrical and mechanical
properties of the heart. Musculoskeletal tissue is similarly organized, with my-
oblasts forming highly aligned muscle fibers through fusion into multi-nucleated
myotubes. This specific arrangement of differentiated myocytes within the mus-
culoskeletal extracellular matrix is essential for the generation of the contrac-
tile force [90]. Additionally, the in vitro characterization of three-dimensional
aligned cells and culture systems will play a fundamental role in future research
activities [91]. When surfaces are uniformly or randomly textured with topo-
graphic features (nodes, pits, protrusions, pillars, channels, etc.) with no di-
rectional order (isotropic), it is expected that cells will not display anisotropic
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alignment. Instead, control of collective cell functions would be expected [89].
Micro-/nanoscale features can elicit a diverse range of cellular behavior. These
engineered surfaces are able to provide important cues either as physical struc-
tures or biochemical adhesive motifs that mediate cell adhesion, spreading,
motility, differentiation, integrin clustering, and subsequent intracellular sig-
naling pathways that regulate gene expression [92]. Cell-nanotopography in-
teractions can induce different effects within a single cell type, owing to the
impact of nanotopography coupled with the physicochemical properties of the
substrate. Cell-nanotopography interactions also vary across cell type, feature
size, and feature geometry [93]. Hierarchical structures consisting of micro- and
nanostructured patterns have been investigated for their effects on cellular ac-
tivities. In some cases, these unique structures have been reported to have
the most significant influence on the proliferation and differentiation of os-
teoblasts [94]. Unlike the reported advantages of micro features that promote
osteoblast differentiation but inhibit their proliferation, micro/nanosized hierar-
chical topography substantially enhanced both differentiation and proliferation
of osteoblasts [95].
Finally, the elastic properties of the substrate materials influence the mechan-
otransduction pathway and ultimately affect the cellular morphology and func-
tion [96]. Many cell types spread more on stiffer substrates or migrate towards
stiffer regions. Properties of fibroblasts, smooth muscle cells, and chondrocytes,
including focal adhesion formation, tyrosine signaling, and proliferation, are all
affected by substrate mechanics across both two-dimensional and three-dimen-
sional cultures. Cell-specific functions of e.g. hepatocytes, mammary epithelial
cells, and spinal neurons are also affected by substrate rigidity [97]. The most
studied biophysical factor is the extracellular matrix stiffness, which controls cell
motility, stem cell differentiation, and tumor progression, among other cellular
phenomena [98]. In particular, the elastic properties of the substrate influence
the lineage specification of MSCs. Soft substrates promote neurogenic differenti-
ation, intermediate substrates promote myogenic differentiation, and the stiffest
substrates promote an osteogenic phenotype. In each case, the elastic modulus
of the substrates matched the properties of the relevant tissue in vivo [99].
2.4 Essential Features of Detonation Nanodiamonds
Nanodiamonds are a novel class of carbon-based nanomaterials and have been
discovered in July 1963 [100]. The first man-made nanodiamonds were pro-
duced by detonating carbon-containing explosives in an oxygen-deficient envi-
ronment to avoid carbon oxidation [101]. The so-called detonation nanodi-
amonds (NDs) are formed by homogeneous nucleation in the volume of the
supersaturated carbon vapor by condensation and crystallization of liquid car-
bon [23]. Figure 2.4 (a) shows the detonation chamber to produce NDs as well
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as the correlated high-resolution transmission electron microscopy (HR-TEM)
image of a single ND particle. However, numerous other methods of nano-
diamond synthesis have been discovered, such as milling from high-pressure
high-temperature (HPHT) diamond microcrystals [102], pulsed laser ablation
[103], microwave plasma chemical vapor deposition [104], high-energy ion
irradiation [105], ultrasound cavitation [106], and selective etching of car-
bides [107]. Despite their synthetic fabrication pathways, nanodiamonds were
found in meteorites and galactic nebulae, proving their natural origin [108].
The following Sections will discuss the diamond nanoparticles formed by the
detonation process since they have a well-established and scalable industrial
production pathway [109,110]. NDs possess a unique combination of properties
with a high diversity of functional surface groups, intrinsic photoluminescence,
and superior mechanical characteristics. Figure 2.4 (b) displays the essential
features of NDs.
The central part of NDs consists of sp3-hybridized carbon atoms. Directly
adjoining the core is a transition layer formed primarily by disordered sp3-hy-
bridized carbon atoms. This near-surface transition region is partially coated by
a graphite-like shell of sp2-hybridized carbon atoms. It is the diamond core that
mainly accounts for the thermal and chemical stability, low electrical conductiv-
ity, quasi abrasiveness, and quasi hardness of NDs. In contrast, the transition
layer, together with the outer functional coating, is responsible for the proper-
ties such as chemisorption, the chemical composition of the functional groups,
and colloidal stability in liquid media [113].
2.4.1 Biomedical Applications
Recently, NDs have emerged as a new platform for biomaterials due to their pho-
toluminescence properties and interfacial integration with a variety of biomole-
cules, including proteins, polymers, chemical drugs, and genes [114]. Table 2.1
exhibits an overview of therapeutic, bioimaging, and biosensing applications of
NDs, while Subsection 2.4.2 gives further details concerning their surface mod-
ification.
The therapeutic applications of NDs are classified into delivery systems of
macromolecules and small biomolecules [126]. Most commonly investigated
small biomolecule delivery systems consist of NDs as nanocarriers for chemother-
apeutics [115,127]. Furthermore, NDs are capable of multimodal small biomol-
ecule delivery applications [116]. However, various macromolecules such as
insulin and BMP-2 have been tethered to NDs to promote tissue recovery and
bone formation [118,119].
NDs possess unique light scattering and photoluminescence properties for
bioimaging applications. Their very high refractive index (n = 2.42) leads to
a high scattering efficiency, which is 300 times higher compared to same-sized
cell organelles embedded in the cytoplasm [128]. Accordingly, NDs are fre-
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Figure 2.4: (a) Commercialized horizontal detonation chamber to produce NDs and the correlated
HR-TEM image of a single ND particle. (b) Essential structural and chemical properties of NDs. Adapted
from [101,111,112].
quently employed as optical scattering labels in biological environments [120].
In contrast, NDs additionally show a strong visible fluorescence emission with
an excitation wavelength dependency on their emission spectra [129]. The flu-
orescence of NDs can be separated into carbon-dot-like and nitrogen-vacancy
fluorescence. Where both, the chemical structure of the graphite-like shell and
disorders of the sp3-hybridized carbon core foster the fluorescent signal [130].
Current fluorescent labels have limitations such as photobleaching, photoblink-
ing, and cytotoxicity, whereas NDs offer a nanodisperse, photostable, biocom-
patible, and scalable alternative [131]. NDs have been applied within in vitro
and in vivo models as fluorescent labels, demonstrating low toxicity and bright
fluorescent signals [132,133]. The cellular uptake of NDs in cancer cells and fi-
broblasts is described as a clathrin-mediated endocytosis process with the active
involvement of the cytoskeletal architecture [122].
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Table 2.1: Detonation nanodiamonds and their biomedical applications in therapy, imaging, and sensors.
Therapy
ND system
/Principle mode of action
ND modification
Biological system /
Assessment
Ref.
Drug delivery system
targeting chemoresistant
tumors
Physisorption of doxorubicin
and NaOH treatment to
promote drug complexing
In vitro and in vivo models of
liver and mammary cancer
cells
[115]
Combined drug delivery
system for doxorubicin and
antibiotic
Physisorption of doxorubicin
and polymyxin B (antibiotic)
targeting Gram-negative
infections
Influence of ND purity,
surface chemistry, and
agglomeration state on the
drug adsorption/desorption
equilibria
[116]
Antimicrobial composite
biomaterial for root canal
therapy using
Physisorption of amoxicillin
for 5:2 and 5:3 (w/w) ratios
of NDs to amoxicillin
Bacteria viability of
Staphylococcus aureus
(S. aureus) and release
kinetics
[117]
Insulin modified NDs
targeting the recovery of
injured tissues
Physisorption of insulin for
5:1 and 4:1 (w/w) ratios of
NDs to insulin
Cell viability of murine
macrophage cells and insulin
function by gene expression
analysis of fibroblasts
[118]
Polymeric scaffolds modified
with BMP-2 functionalized
NDs
Chemisorption and
physisorption of BMP-2
In vitro mineralization of
primary hMSCs and in vivo
rat model in combination
with histological analysis
[119]
Bioimaging
Imaging of NDs as scattering
optical labels
Electrostatic binding and
entrapment by liposomes
NDs internalized into 3T3
mammalian epithelial cells
and optical microscopy
[120]
Long-term in vivo imaging
Chemisorption of dextran
and BSA
Distribution and toxicity of
NDs in soil nematode
Caenorhabditis
elegans (C. elegans)
[121]
Cellular uptake mechanism
of NDs
Pristine surface chemistry
and chemisorption of
poly-L-lysine
Flow cytometry experiments
of human cervical cancer
cells and fibroblasts
[122]
Biosensor
Detection of cancer
metastasis biomarkers
Chemisorption of
fluorescent-labeled peptides
In vitro microfluidic cell
culture of liver cancer cells
[123]
Thermometry in living cells
Electrostatic binding to
vertical silicon nanowires
Confocal microscopy of
fibroblasts
[124]
Electrochemical biosensor
for detecting phenolic
compounds
Physisorption of potato
starch
Differential pulse
voltammetry and cyclic
voltammetry
[125]
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Biosensors integrating NDs take advantage of their fluorescent properties and
binding capabilities. ND biosensors have been developed in combination with
peptides, which are respectively cleaved by a metastasis biomarker enzyme.
Those peptides were tethered to NDs and used as a stimuli-responsive metas-
tasis detection tool [123]. Fluorescent NDs were used to perform thermometry
in living cells [124]. Furthermore, ND biosensors exhibit a low detection limit
of harmful phenolic compounds and enable ratiometric detection of hydrogen
peroxide [125,134].
Besides their biomedical applications, NDs are applied in numerous appli-
cations due to their excellent properties (see Section 2.4). NDs decrease the
friction coefficient in engine oils due to their high wear resistance and nanopol-
ishing effect [135,136]. The application of NDs in elastomers has allowed prac-
tical implementation of the difficult-to-achieve effect of providing high strength
characteristics while retaining the elasticity of polymers [137]. Apart from their
superior mechanical properties, NDs exhibit great potential as contrast agents in
magnetic resonance imaging at ultra-low magnetic fields [138]. Moreover, NDs
are used as antimicrobial agents [139]. The ability of NDs to kill Gram-positive
and Gram-negative bacteria strongly depends on their surface chemistry. NDs
containing partially oxidized surfaces demonstrate a high bactericidal activity
due to the interaction of bacteria with the reactive oxygen-containing surface
groups and the subsequent alterations in bacterial surfaces [140].
2.4.2 Chemical Functionalization Pathways
The interactions of cells with nanoparticles are significantly affected by their
surface chemistry [141]. Moreover, the functional surface groups of nanopar-
ticles have been recognized as key design parameters for drug delivery plat-
forms [142]. In order to modify the surface of NDs, various high-temperature
gas treatments and ambient-temperature wet chemistry pathways have been
developed. Figure 2.5 displays an overview of the prevalent ND surface modifi-
cation routines.
The stability of the functional surface groups plays a vital role in different
modification pathways of NDs [146]. NDs have been annealed in vacuum or
inert gas to graphitize their surface [147]. Additionally, the sp2-hybridized car-
bon shell around the diamond core is amenable to various C-C bond formation
reactions, for example, arylation by aryldiazonium salts, Diels-Alder reaction,
Prato reaction, and Bingel-Hirsch reaction [143]. The activation of the car-
boxylic acids on the ND surfaces using 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide (EDC) and N-hydroxysuccinimide (NHS) provides the possibility to
tether various small biomolecules or macromolecules. Gaillard et al. grafted
peptide nucleic acids onto NDs to detect DNA [148]. Furthermore, NDs have
been PEGylated using EDC and NHS to act as smart pH-responsive drug delivery
vehicles and fluorescent probes [149,150]. Hydrogenation of NDs has been per-
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Figure 2.5: Significant surface modification pathways of oxidized NDs. Adapted from [23,143–145].
formed using H2 plasma treatment or annealing in H2 atmosphere [151, 152].
Girard et al. discussed the biological application of hydrogenated NDs possess-
ing alkenes and diazonium moieties [153]. Several functional organic groups
such as halides, amines, cyanide, azide, and thiols were grafted onto hydroxy-
lated NDs [154]. Moreover, hydrogenated NDs are investigated in the context
of radiosensitization applications [155]. The reduction of oxidized NDs using
BH3 ·THF and LiALH4 yields hydroxylated NDs [156, 157]. Hydroxylated NDs
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find their application in polymer grafting and to tether long alkyl chains [158,
159]. Moreover, silanes were grafted onto hydroxylated NDs as linkers to bi-
otin, fluorescein isothiocyanate, and DNA [156,160,161]. In general, silanized
NDs are fillers in polymer nanocomposites [162, 163]. Ammonia-treated NDs
exhibit a relatively high conductivity compared to untreated NDs, which appear
to relate to grain interior conduction and grain boundary conduction [164].
In order to alter the solubility of NDs in different solvents and to improve the
interfacial adhesion within nanocomposites, NDs have been functionalized by
amino groups following the wet chemistry pathway [165]. Moreover, NDs have
been modified using high-temperature annealing in ammonia, where a mixture
of C H, C N, NH2, C O and O H containing surface functionalities was ob-
tained [166, 167]. Surface chlorination of NDs has been accomplished using
wet chemistry pathways, photochemical reactions, and electron beam irradia-
tion [168–170]. In particular, acyl chloride functionalized NDs are essential for
drug and gene delivery applications. Wang et al. presented chlorinated NDs as
delivery vehicle for chemotherapeutics in combination with additional PEGyla-
tion [171]. Acyl chloride functionalized NDs have been applied for subsequent
tethering of lysine to act as suitable nonviral vectors for transferring genetic
materials across cellular membranes [172]. Furthermore, nylon 6,6 polymer
composites were reinforced using acyl chloride functionalized NDs showing en-
hanced mechanical properties and thermal conductivities [173]. NDs have been
fluorinated and applied in neutron reflectors where the NDs opened the way to
the design of a new generation of neutron sources and experiments [174,175].
2.4.3 Colloidal Stability
Although the presence of disordered sp3-hybridized carbon atoms and func-
tional surface groups can be utilized from the viewpoint of nanoparticle surface
modification, it is rather unfavorable because it causes strong agglomeration of
primary ND particles, forming secondary agglomerates up to 100 nm or even
larger [176]. NDs principally agglomerate due to contaminations by heavy met-
als, Coulombic inter-particle attractions, and covalent bonding [177–179]. Fig-
ure 2.6 summarises the possible agglomeration models for carboxylated and hy-
droxylated NDs based on (a) hydrogen bonding and (b) covalent inter-particle
attraction [180].
While some degree of nanoparticle clustering is regularly observed for in vivo
applications, nanoparticles possessing primary particle diameters in ranges be-
low 6 nm can filter through the capillaries of the glomerulus in the kidney and be
cleared rapidly [181]. Efficient disaggregation techniques of NDs are required
since the higher specific surface area of disaggregated NDs comes with a greater
capacity for carrying therapeutic agents, biomarkers, and ligands [182]. Vari-
ous mechanical disaggregation techniques have been investigated to decrease
the ND agglomerate size namely bead milling [183], beads-assisted sonica-
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Figure 2.6: Agglomeration of carboxylated and hydroxylated NDs due to (a) hydrogen bonding and (b)
covalent interaction. Adapted from [180].
tion (BASD) [184], salt- and sugar-assisted stainless steel bead milling [185],
and salt-assisted ultrasonic deaggregation (SAUD) [186]. The underlying mech-
anism of the ultrasound disaggregation is based on the strong hydrodynamic
forces caused by the formation and rapid collapse of small vacuum bubbles in
the liquid medium, a process known as acoustic cavitation [187]. The applica-
tion of different suspending agents facilitates the steric and electrostatic repul-
sion between NDs. Biodegradable polyurethane has been grafted onto NDs to
increase the colloidal stability in organic solvents [188].
Furthermore, polyelectrolytes were applied to stabilize ND suspensions due
to an enhanced electrostatic repulsion force [189]. The deprotonation of func-
tional surface groups alters the colloidal stability because the pKa of the func-
tional groups are responsible for the acid-base behavior of the colloid [190].
In general, factors such as zeta potential, ionic strength, and pH of the solvent
along with surface composition influence the colloidal stability of the ND sus-
pension [191, 192]. As-received NDs suspended in dimethyl sulfoxide (DMSO)
exhibiting a positive zeta potential provide significant advantages in achiev-
ing resistance to sedimentation and are utilized in seeding slurries [193]. NDs
with a high number of oxygen-containing functional surface groups demonstrate
higher colloidal stability in water compared to their untreated surface [194].
The calculations of Raty et al. showed that NDs with size in the 2-4 nm range
exhibit a hybrid structure called bucky diamond made of diamond core and a
fullerene-like surface [195]. Raty et al. further demonstrated by ab initio calcu-
lations that for NDs with sizes down to 3 nm, it is energetically more favorable
to have a bare, reconstructed surface rather than hydrogenated surface [196].
In the light of these works, it is clear that the smallest ND with sizes down to
2 nm can be energetically stable [197].


3 Materials and Methods
This chapter presents the conducted experiments and employed materials. The
experimental schedule and implementation are shown in Figure 7.1 while the
list of all used materials and corresponding suppliers is displayed in the Ap-
pendix. Section 3.1 of the present chapter describes the oxidation pathways
of detonation nanodiamonds (NDs) followed by Section 3.2 related to the uti-
lized disaggregation techniques of ND agglomerates. Section 3.3 addresses the
grafting process of biomolecules onto NDs and Section 3.4 refers to the macro-
scopic surface modification methods. The last Section 3.5 outlines the applied
characterization techniques.
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Figure 3.1: Outline of the experimental schedule and the correlated characterization techniques.
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3.1 Wet Chemical and High-temperature Oxidation of Detonation Nano-
diamonds
The as-received NDs employed in this work were purchased from PlasmaChem
GmbH, Berlin, Germany. The declared average particle size is 4 nm. In order to
alter the ND surface, wet and dry oxidation pathways were utilized.
NDs have been oxidized using strong acids in the case of the wet chemistry
course. Wet-oxidized NDs were obtained after the oxidation of 2 g as-received
NDs in 50 ml of a 3:1 (v/v) mixture of 95% (w/w) H2SO4 and 30% (w/w)
H2O2 at 90 °C for 24 h under stirring conditions. Alternatively, as-received NDs
were oxidized using a procedure similar to Teeling-Smith et al [198]. Briefly,
2 g of as-received NDs were heated in 50 ml of a 9:1 (v:v) mixture of 95%
(w/w) H2SO4 and 70% (w/w) HNO3 at 75 °C for 72 h, subsequently in 50 ml of
0.1 M NaOH aqueous solution at 90 °C for 2 h, and then in 0.1 M HCl aqueous
solution at 90 °C for 2 h. Type 1 ultrapure water (ddH2O) was collected through
a Direct-Q 3 UV System water purifier by Merck KGaA, Darmstadt, Germany.
The wet-oxidized NDs were washed with ddH2O three times before collecting
via centrifugation. Centrifugation has been conducted on the high-speed micro-
liter centrifuge MIKRO 200R by Andreas Hettich GmbH & Co. KG, Tuttlingen,
Germany.
The dry oxidation of NDs was performed using air annealing at 415 °C at
a heating rate of 20 K/min for 5 h in a high-temperature muffle furnace by
Thermconcept GmbH (model HTK 16/17), Bremen, Germany.
3.2 Disaggregation of Detonation Nanodiamond Agglomerates
Disaggregation techniques are required to increase the surface area of NDs and
to enhance the correlated number of exposed functional surface groups.
Bead milling has been applied to disaggregate NDs. Therefore, 0.75 g of
as-received NDs were suspended in 15 ml of ddH2O along with 7.5 g of Y-stabi-
lized ZrO2 microbeads as the grinding medium. The microbeads were 100 µm in
diameter and purchased from Sigmund Lindner GmbH, Warmensteinach, Ger-
many. Grinding bowls containing the aqueous ND suspension were subjected
to high-speed rotation using the planetary micro mill Pulverisette 7 by Fritsch
GmbH, Idar-Oberstein, Germany. The milling treatment consisted of two consec-
utive cycles at 700 rpm for 30 min each with an intermediate break of 10 min.
The collected ND suspension was then vacuum-filtered using a ceramic filter
system by DWK Life Sciences, Millville, NJ, USA, and subsequently sonicated
for 30 min using a Sonopuls HD 2200 ultrasonic homogenizer by Bandelin elec-
tronic GmbH & Co. KG, Berlin, Germany. The applied oscillation frequency of
the submerged ultrasound probe was 20 kHz at 70% of the instrument’s power
output operated on pulsed cycles with 0.7 s active and 0.3 s passive intervals.
Alternatively, NDs have been disaggregated using salt-assisted ultrasonic deag-
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gregation (SAUD) adapted from Turcheniuk et al [186]. The previously disag-
gregated ND suspension was diluted with ddH2O to a final concentration of
1 mg/ml. Subsequently, the ND suspension has been oversaturated using NaCl,
where the resulting concentration of NaCl was greater than 60 wt%. The solid
salt crystals acted as the grinding medium during the additional four cycles
of the 30 min ultrasound sonication. Afterward, the ND suspension was cen-
trifuged at 2 000 g for 10 min at room temperature (RT) using a Sigma 3-16PK
centrifuge by Sartorius AG, Goettingen, Germany. The clear supernatant was
removed and the ND pellets were washed in ddH2O for three times.
3.3 Grafting of Biomolecules onto Detonation Nanodiamonds
Electrostatic attraction and covalent grafting of biomolecules have been used to
add multiple functionalities to NDs, encompassing the increase in antimicrobial
properties and the introduction of specific cellular stimulation.
The electrostatic surface modification of NDs comprised the application of
polyelectrolytes and physisorption of antibiotics. The positively charged poly-
electrolyte polydiallyldimethylammonium chloride (PDDA) has been used to al-
ter the electric charge of NDs. The PDDA solution was diluted to the final con-
centration of 20 mg/ml. The ND suspension with a concentration of 1 mg/ml
was mixed with the diluted PDDA solution at a 1:1 volume ratio for 10 min.
Afterward, the ND-PDDA suspension was equally distributed into several micro-
centrifuge tubes. Centrifugation was performed using high-speed centrifugation
at 15 000 rpm and RT for 30 min. The supernatant was removed and the ND pel-
lets were washed twice in ddH2O. Finally, ND-PDDA complexes were incubated
in a ThermoMixer® by Eppendorf AG, Hamburg, Germany at 700 rpm and RT
with amoxicillin at 1:1 concentration ratio for 60 min and 9 days. The respective
solution of antibiotics had a concentration of 1 mg/ml. The ND-PDDA-antibiotic
complexes were washed once in ddH2O before collecting.
The bone morphogenetic protein-2 (BMP-2) derived peptide with the se-
quence KIPKASSVPTELSAISTLYLGGC was covalently grafted onto as-received
and dry-oxidized NDs using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
(EDC) and N-hydroxysuccinimide (NHS). Therefore, 0.4 mg of EDC and 0.6 mg
of NHS were successively added per 1 ml of the ND suspension to a final con-
centration of 2 mM and 5 mM, respectively. The employed ND suspension pos-
sessed a concentration of 1 mg/ml. The chemicals were allowed to react at RT
for 5 min. Subsequently, 1.4 µl of 2-mercaptoethanol per 1 ml of ND suspension
(final concentration of 20 mM) was added to quench the EDC. The peptide was
directly suspended into the NHS-activated ND suspensions to a final concentra-
tion of 100 µg/ml of the peptide. The ND-peptide mixture was incubated at
700 rpm and 37 °C for 24 h. Afterward, the ND suspensions were centrifuged at
14 000 g using the MiniSpin®-plus centrifuge by Eppendorf AG, Hamburg, Ger-
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many for 30 min. The supernatant was collected to determine the amount of
the unbound peptide and the peptide-conjugated ND pellets were washed twice
with ddH2O.
3.4 Macroscopic Surface Modification of Biomaterials
Metallic biomaterials and glass-ceramics are depicted in the present thesis by
commercially pure grade 4 titanium (Ti) and silica glass. Both materials were
coated using various techniques by untreated and peptide-conjugated NDs to
control the topography and functionality of their surfaces. Before coating, all
substrates employed in any surface modification process were cleaned succes-
sively using ultrasound treatment in ethanol, acetone, and ddH2O for 5 min.
Ti has been coated with as-received NDs using dip coating, electrophoretic
deposition (EPD) and covalent attachment by silanized surfaces. In course
of the dip coating process, substrates have been immersed in the ND suspen-
sion at a speed of 200 mm/s, left in the suspension for one hour, and with-
drawn at a speed of 50 mm/s using the KSV Nima dip coater by Biolin Scien-
tific Holding AB, Stockholm, Sweden. The substrates were placed in the ND
suspension and linked to the electric circuit in the case of the EPD treatment.
A platinum sheet electrode by Sensortechnik Meinsberg GmbH, Waldheim, Ger-
many was used as the counter electrode. The circuit was controlled using the
IviumStat.h impedance analyzer, Ivium Technologies BV, Eindhoven, Nether-
lands to define the potential of 3 V and the exposure time of 10 min. Figure 3.2
shows the schematic illustration of the covalent attachment strategy. Prior to
the covalent attachment, all substrates underwent O2 plasma treatment using
a Femto plasma system by Diener electronic GmbH & Co. KG, Ebhausen, Ger-
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Figure 3.2: Covalent attachment of oxidized NDs using (3-aminopropyl)triethoxysilane (APTES)
and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide (EDC/NHS) activation.
Adapted from [199].
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many for 2-5 min. The silanization process took place in an aqueous mixture of
2% (3-aminopropyl)triethoxysilane (APTES) with 95% absolute ethanol, which
was left to hydrolyze for 10 min. The substrates were placed in the silanization
bath and incubated for 4 h. Subsequently, the substrates were washed three
times in absolute ethanol and blow-dried with N2. The final drying stage re-
quired heating at 120 °C for 30 min. Oxidized NDs were bonded to the silanized
surface via EDC/NHS-mediated amide formation: equal volumes of the 1 mg/ml
ND suspension and 100 mM of 2-(N-morpholino)ethanesulfonic acid (MES)
buffer were mixed, and the silanized substrates were immersed. Afterward,
the coupling took place by adding, dropwise, the first 7.5 mM of EDC, and then
7.5 mM of NHS to reach a total concentration of 4.7 mM each. The substrates
were incubated for 20 min, washed with ddH2O, and blow-dried with N2.
Ti and silica glass were coated with NDs using polyelectrolyte multilayers
(PEMs). Figure 3.3 illustrates the application of PEMs. The substrates have
been treated in O2 plasma with an operating pressure of 400 mTorr, oxygen flow
rate of 40 sscm, and plasma power of 200 W using a plasma system by SNTEK
Co., Ltd, Suwon-si, Republic of Korea for 60 s. PEMs of negatively charged NDs
with PDDA or poly-L-lysine (PLL) were obtained via layer-by-layer processing.
The cleaned and O2 plasma-treated substrates were successively dip-coated for
10 min in 50 ml of an aqueous 2 mg/ml PDDA or 0.1 mg/ml PLL solution and
afterward in 50 ml of a 1 mg/ml ND suspension with an intermediated rinsing
step of 10 min in ddH2O. This process resulted in bilayers of NDs and polyelec-
trolytes on the substrates. The maximum of five bilayers was applied.
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Figure 3.3: Surface modification via polyelectrolyte multilayers (PEMs) containing NDs.
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3.5 Characterization Techniques
Several characterization techniques have been used to determine, among other
properties, the surface chemistry of the employed NDs and to investigate the
structure as well as the biological response to the biomaterials with ND coat-
ings. Therefore, Subsection 3.5.1 addresses the details of the topography mea-
surements. Subsection 3.5.2 explains the experiments regarding the colloidal
stability of ND suspensions and the structural investigation. Subsequently, Sub-
section 3.5.3 specifies the assessment of the ND chemistry and surface loading.
Subsection 3.5.4 outlines the alkaline phosphatase activity measurements of hu-
man mesenchymal stem cells, while Subsection 3.5.5 describes the investigation
related to the cell viability of human fetal osteoblasts.
3.5.1 Morphology
The topography of the substrates has been analyzed via scanning electron mi-
croscopy (SEM) using either an XL30 ESEM by Koninklijke Philips NV, Ams-
terdam, Netherlands or a JSM-7100F by JEOL Ltd., Tokyo, Japan. Samples
were sputter-coated with a 5 nm layer of Au using a Q300TD sputter coater by
Quorum Technologies Ltd., Lewes, United Kingdom, and subsequently imaged
with an electron-accelerating voltage of 3-8 kV. The surface morphology and
roughness were determined via atomic force microscopy (AFM), using either a
NanoWizard® 2 by Bruker Nano GmbH, Berlin, Germany or an XE100 by Park
Systems Corp., Seoul, Republic of Korea, where both systems were operated in
non-contact mode.
3.5.2 Colloidal Stability and ND Crystal Structure
The pH of ND suspensions was adjusted by adding either 357 mM H2SO4 or
1 M NaOH. The ND agglomerate size distribution and the correlated zeta poten-
tial of the ND suspension have been determined using dynamic light scattering
(DLS). Therefore, either a Delsa Nano Submicron Zetasizer by Beckman Coulter
Inc., Brea, CA, USA or a Nano ZS by Malvern Panalytical GmbH, Kassel, Ger-
many were used to assess the colloidal stability of ND suspensions. Before the
measurements, ND suspensions were homogenized for 5 min using an ultrasonic
cleaner by VWR International GmbH, Darmstadt, Germany. The folded polycar-
bonate capillary zeta cell (model: DTS1070) by Malvern Panalytical GmbH,
Kassel, Germany with inbuilt gold plated copper electrodes or a quartz cuvette
with a light path of 1 cm purchased from Hellma GmbH & Co. KG, Müllheim,
Germany were employed. Each measurement was repeated at least three times
with an intermediate cleaning step of the cuvette with ethanol and ddH2O.
The ND crystal structure has been investigated via X-ray diffraction using
a D8 XRD by Bruker Corp., Billerica, MA, USA in combination with a copper
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Kα X-ray radiation source at 40 kV and 40 mA. Transmission electron microscopy
(TEM) was applied to image NDs using a JEM1400 plus by JEOL Ltd., Tokyo,
Japan.
3.5.3 ND Surface Chemistry and Surface Loading
In order to determine the functional surface groups of NDs, Fourier-transform
infrared (FT-IR) spectroscopy and inductively coupled plasma optical emission
spectrometry (ICP-OES) were used. Infrared absorption spectra of NDs were
recorded from 400 cm-1 to 4 000 cm-1 with 32 scan cycles and resolution of
1 cm-1 using a Vertex 70 FTIR spectrometer by Bruker Corp., Billerica, MA,
USA in pellets with KBr (1:100 mass ratio of sample to KBr). Inductively cou-
pled plasma optical emission spectrometry (ICP-OES) was used to quantify the
ND surfaces using the selective sodium ion exchange of NaHCO3 to carboxylic
acids. Therefore, 1.5 g NDs were mixed with 50 ml of 0.05 M NaHCO3 ac-
cording to the Boehm titration method [200]. The mixture was allowed to
react at 40 °C for 24 h. Afterward, centrifugation at 4 000 g was conducted
using an Allegra® X-15R centrifuge by Beckman Coulter Inc., Brea, CA, USA
with a swinging-bucket rotor and 10 kDa Amicon® ultra centrifugal filters by
Merck KGaA, Darmstadt, Germany for 30 min. The sodium content of the initial
and reacted NaHCO3 was determined using the Optima 8300 by PerkinElmer
Inc., Waltham, MA, USA. The device was operated by 1 500 W at 40 MHz with
12 l/min plasma gas flow and calibrated using 1% HNO3.
The surface loading of NDs was determined using ultraviolet-visible (UV/Vis)
and fluorescence spectroscopy (FS). FS was used to quantify the amount of
BMP-2 derived peptide grafted onto NDs. The instrument used for fluores-
cence emission measurements was a Fluoromax-4 spectrofluorometer by Horiba
Ltd., Kyoto, Japan. The calibration was set using serial two-fold dilutions of
100 µg/ml aqueous peptide solution. The excitation wavelength was 274 nm
and the emission was measured in the range of 290-350 nm with a slit opening
of 5 nm and in increments of 0.5 nm. The amount of loaded amoxicillin has been
assessed using UV/Vis spectroscopy. The absorbance of the amoxicillin solution
was measured in the range of 257-289 nm using the UV-3600 Plus spectrome-
ter by Shimadzu Corp., Kyoto, Japan. In order to quantify the surface loading
of NDs, the concentration of unbound biomolecules was used to calculate the
surface loading.
3.5.4 Alkaline Phosphatase Activity of Human Mesenchymal Stem Cells
The osteogenic capabilities of Ti substrates modified by peptide-conjugated NDs
have been evaluated using cell culture experiments with human mesenchy-
mal stem cells (hMSCs) collected from a healthy patient’s bone marrow. The
procedure was approved by the ethics committee of the Faculty of Medicine,
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University of Leipzig, Germany. Modified NDs with BMP-2 derived peptide on
their surface were immobilized on Ti substrates using poly-L-lysine. The mod-
ified Ti substrates were washed with 70% ethanol and placed in 12-well cul-
ture plates. The hMSCs in a growth medium consisting of low glucose DMEM,
10% fetal bovine serum and 1% penicillin-streptomycin were seeded at 1 × 104
cells/cm2 on the Ti substrates. The cells were allowed to adhere for 24 h and
after the medium was changed to an osteogenic induction medium consisting
of 100 µM L-ascorbic acid 2-phosphate, 10 nM dexamethasone, and 10 mM
β-glycerophosphate. The hMSCs were cultivated at 37 °C in 5% CO2 atmo-
sphere for seven days and the cell culture medium was changed after 3 days.
Seven days after cultivation cells were lysed in radioimmunoprecipitation assay
(RIPA) buffer. The alkaline phosphatase (ALP) enzyme activity was determined
using p-nitrophenyl phosphate as a phosphatase substrate, which turns yellow
(λmax = 405 nm) when dephosphorylated by ALP. The enzyme activity was cal-
culated using a p-nitrophenol standard curve. For the final calculation of ALP
activity in U/µg protein the protein content of the sample was determined. The
ALP activity of the cultured cells was measured spectrophotometrically using an
Infinite® M1000 by Tecan Trading AG, Männedorf, Switzerland.
The hMSCs were stained with Alexa Fluor™ 594 Phalloidin, monoclonal Vin-
culin antibody with anti-rabbit Cy3 as a secondary antibody along with DAPI.
The imaging was performed using a DMI4000B fluorescence microscope by
Leica Microsystems GmbH, Wetzlar, Germany.
3.5.5 Cell Viability and Immunofluorescence Staining of Human Fetal Osteoblasts
Bare and ND modified silica glass substrates were washed with 70% ethanol
and placed in 12-well culture plates. In order to facilitate cell attachment, bare
silica glass was coated with fibronectin before cell seeding. In brief, bare sil-
ica glass was soaked into 30 ng/µl fibronectin dissolved in phosphate-buffered
saline (PBS) for 4 h and dried at RT under ambient air conditions for 1 h. Hu-
man fetal osteoblasts (hFOB 1.19; ATCC® CRL-11372™, Manassas, VA, USA)
were cultivated in Dulbecco’s Modified Eagle’s Medium at 5% CO2 and 37 °C for
24 h. A cell suspension of 5 × 104 cells were resuspended and seeded on a cell
culture plate. After several hours of cell seeding, the cell culture medium was
changed to maintain only adhered cells. After 24 h of cultivation, substrates
were washed with PBS and the adhered cells were used to conduct immunoflu-
orescence staining. Cells were fixed using 4% paraformaldehyde in PBS at RT
for 20 min and washed three times with PBS. Before staining, the fixed cells
were subsequently permeabilized with 0.5% Triton X-100 for 5 min and blocked
in 5% bovine serum albumin (BSA) in PBS at RT for 60 min. The samples were
incubated using a mixture of vinculin primary antibody (1:200) diluted in 5%
BSA and Alexa Fluor™ 633 Phalloidin diluted in 5% BSA (1:40) at 37 °C for 1 h.
The samples were washed two times with PBS to remove any excess, followed
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by incubation with a fluorescence-labeled secondary antibody (goat anti-mouse
Alexa Fluor™ 488) diluted in 5% BSA at RT for 30 min. Finally, cell nuclei were
stained by mounting solution with DAPI (4’,6-diamidino-2-phenylindole).
Confocal microscopy of the stained hFOBs has been performed using an
LSM 700 by Carl Zeiss AG, Oberkochen, Germany. Fluorescence images were
analyzed using the ImageJ software (National Institutes of Health, USA) [201].
The protein distribution per cell and area of osteoblasts as a degree of spreading
were expressed as mean standard deviation and analyzed with t-tests to estimate
statistical relevance.
Cell viability was measured using the colorimetric Vybrant® MTT cell prolif-
eration assay kit. The 5 × 104 hFOBs were cultured in 12-well culture plates in
Dulbecco’s Modified Eagle’s Medium, with six duplicate wells in each group. The
cells were incubated at 37 °C for 12 h. The cell culture medium was removed
and washed with PBS. The cells were subsequently cultured for 3 h after 500 µl
of MTT reagent was dispensed. When the purple precipitate was observed via
optical microscopy, 200 µl of dimethyl sulfoxide (DMSO) was carefully added
and transferred to a 96-well culture plate. The absorbance in each well was
measured using the microplate reader VersaMax™by Molecular Devices, San
Jose, CA, USA with a 570 nm-wavelength filter. The mean optical density (OD,
absorbance) of six wells in the indicated groups was used to calculate the per-
centage of cell viability as follows: percentage of cell viability = (ODsample -
ODblank) / (ODcontrol - ODblank) × 100%. The error propagation was calculated
regarding the maximum uncertainty.

4 Surface Modification of Detonation Nanodiamonds
As-received detonation nanodiamonds (NDs) have been modified using wet
chemical and high-temperature oxidation. Section 4.1 discusses and evaluates
both oxidation pathways concerning their efficiency. Subsequently, Section 4.2
describes the surface loading of NDs by bone morphogenetic protein-2 derived
peptide via a carboxyl-reactive crosslinking approach. The successful surface
loading has been assessed using infrared and fluorescence spectroscopy. Sec-
tion 4.3 presents the outcome concerning the physisorption of an antibiotic,
namely amoxicillin, onto NDs.
4.1 Comparison of Wet Chemical and High-temperature Oxidation
In order to enrich the ND surface with carbonyl compounds, wet and dry oxida-
tion has been conducted. Figure 4.1 exhibits a schematic overview of the ND ox-
idation and Section 3.1 reveals the details of the utilized materials and methods.
Absorption spectroscopy such as Fourier-transform infrared (FT-IR) spectroscopy
and inductively coupled plasma optical emission spectrometry (ICP-OES) mea-
surements of various ND surface modifications were performed to determine
the functional surface groups. Accordingly, the quantitative number of carbonyl
compounds on the ND surface has been calculated. X-ray diffraction (XRD) was
conducted to assess the crystal structure of NDs.
4.1.1 Absorption Spectroscopy
Crosslinking techniques of biomolecules which possess amide or thiol groups
require deprotonated carbonyl compounds [202–204]. In order to increase the
number of carbonyl-containing surface groups on NDs, wet and dry oxidation
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Figure 4.1: Schematic representation of the wet and dry oxidation of as-received NDs.
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present a promising pathway [145]. Figure 4.2 compares the infrared spectra
of the as-received, wet-, and dry-oxidized NDs. As shown in Figure 4.2 (a),
oxidized NDs possess similar stretch vibrations of νO H at 3660-3300 cm-1,
νC C at 1630 cm-1, and νC O at 1105 cm-1 [205, 206]. The carbonyl stretch
vibrations νC O are expected at 1850-1710 cm-1, in which νC O of acid anhy-
drides are observed at 1800 cm-1 and νC O of carboxylic acids at 1760 cm-1,
respectively [207]. Figure 4.2 (b) displays the FT-IR spectra in the range of
1460-1960 cm-1. The intensity of carbonyl stretch vibrations (νC O) increases,
and sp2 carbon (νC C) decreases for dry-oxidized NDs compared to as-received
and wet-oxidized NDs. Therefore, the wet oxidation increases the number of
carboxylic acids on the ND surface, whereas dry oxidation additionally leads
to their conversion into acid anhydrides, which can be observed as the νC O
peak shift to higher wavenumbers. The conversion of functional ND surface
groups into acid anhydrides is favorable in the absence of water and requires
the dehydration of carboxylic acids. The present thesis reports the formation of
acid anhydrides on the ND surface after air annealing at 415 °C for 5 h, while
Sotoma et al. observed the acid anhydride formation at 600 °C for 5 h [208]. Ad-
ditionally, Dideikin et al. indicated an sp3-sp2 rehybridization of carbon atoms at
450 °C and annealing time of 1 h [209]. The conversion of functional ND surface
groups into carbonyl compounds is strongly related to the initial sp3/sp2 carbon
ratio, which depends on the actual manufacturer [210].
In order to compare the surface chemistry of the oxidized NDs, the inten-
sity ratio of νC O and νC C compounds was calculated. Accordingly, a high
intensity ratio of I(νC O)/I(νC C) represents an absolute higher number of car-
bonyl compounds on the ND surface. As shown in Figure 4.3 (a), the highest
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Figure 4.3: Comparison of as-received, wet-, and dry-oxidized NDs. (a) Infrared absorbance ratio of
carbonyl (νC O) to sp2 carbon (νC C) and (b) surface loading of carboxylic acid derivatives on the ND
surface obtained from ICP-OES.
infrared absorbance ratio of I(νC O)/I(νC C) was obtained for dry-oxidized
NDs. Wet-oxidized NDs have 2.3-fold while dry-oxidized NDs possess 3.2-fold
from the number of carbonyl compounds of as-received NDs. The area under-
neath the respective peak of the infrared spectra has been evaluated to calcu-
late the intensity ratios. In order to quantify the number of carboxylic acid
derivatives, mass spectroscopy was conducted. Figure 4.3 (b) shows the num-
ber of carboxylic acid derivatives on the ND surface. As-received NDs reveal
0.07 ± 0.01 mmol/g, wet-oxidized NDs 0.08 ± 0.01 mmol/g, and dry-oxidized
NDs 0.11 ± 0.01 mmol/g of carboxylic acid derivatives. The specific dissoci-
ation of Na+ ions decomposed from NaHCO3 to carboxylic acids was used to
determine the total surface loading of NDs [211]. Despite the different carbonyl
species, NDs with a high number of acid anhydrides show the highest number
of Na+ ions on their surface. Aqueous alkaline media are able to regenerate
carboxylic acids from acid anhydrides [212]. Therefore, acid anhydrides will
be hydrolyzed to carboxylic acids which in turn act as compounds to bind for
example biomolecules to the ND surface.
4.1.2 Crystal Structure of Dry-oxidized NDs
The crystal structure of NDs has to be preserved during the high-temperature
oxidation. Figure 4.4 shows the X-ray diffraction (XRD) pattern of as-received
38 4 Surface Modification of Detonation Nanodiamonds
and dry-oxidized NDs, which proves the maintained diamond crystal structure
by means of XRD analysis. The reflections of the diamond planes (111) and
(220) are evident in the diffraction pattern at 2θ = 43.7° and 2θ = 75.3°, re-
spectively [213]. If all the line broadening is attributed to the effect of the small
grain size, according to the Scherrer formula, the length of the grain can be cal-
culated as 3.7 nm for the dry-oxidized and 4.8 nm for the as-received NDs [214].
The broad and asymmetric reflection centered on 2θ = 22.3° is attributed to a
graphitized carbon shell (002) and amorphous carbon [215,216]. Upon the an-
nealing of NDs, the amorphous carbon will start to decompose at 200 °C, which
results in a 55% decrease in the intensity ratio of the reflection I(002)/I(111) for
dry-oxidized NDs compared to as-received NDs [217]. However, the graphitized
carbon shell remains stable until 900 °C [218].
4.2 Chemisorption of Bone Morphogenetic Protein-2 Derived Peptide
The bone morphogenetic protein-2 (BMP-2) derived peptide with the sequence
KIPKASSVPTELSAISTLYLGGC has been grafted to as-received and dry-oxidized
NDs. Figure 4.5 displays the outline of the covalent functionalization pathway of
NDs using the BMP-2 derived peptide in combination with an EDC/NHS-medi-
ated amide formation [219]. In order to quantify the amount of peptide grafted
onto NDs, fluorescence spectroscopy was applied. As shown in Figure 4.6 (a),
the integral autofluorescence intensity around 302 nm of the BMP-2 derived
peptide was used to correlate its concentration. The fitted regression line in
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Figure 4.5: Schematic representation of the covalent grafting of BMP-2 derived peptide onto oxidized NDs.
Figure 4.6 (b) exhibits a high coefficient of determination with 99.785%, which
refers to the little variability of the obtained data. The amount of BMP-2 derived
peptide grafted onto NDs was calculated by subtracting the amount of unbound
peptide from the initial quantity after conjugation.
Figure 4.7 shows the surface loading of NDs with the peptide including the
corresponding FT-IR measurements. Figure 4.7 (a) indicates the surface loading
efficiency of the peptide on NDs, where 100 µg/ml of the peptide were loaded
onto 100 µg/ml (1:1 ND-peptide) and 500 µg/ml (5:1 ND-peptide) of NDs, re-
spectively. In general, the dry-oxidized NDs show a higher amount of the peptide
on their surface, although the difference to as-received NDs is non-significant
for a high quantity of tethered peptide. The dry-oxidized NDs have an absolute
surface loading efficiency of 49 ± 4%, which is 17 ± 2% higher compared to
the as-received NDs in the case of the 1:1 ND-peptide ratio without EDC/NHS.
While with EDC/NHS activation the absolute surface loading of as-received NDs
is 84 ± 2% and dry-oxidized NDs 87 ± 3%. Following the EDC/NHS-mediated
conjugation, the interaction of the peptide with NDs is based on chemisorption,
wherein peptides are mainly adsorbed onto NDs without EDC/NHS. The signif-
icantly higher amount of tethered peptide using EDC/NHS and the influence
of different ND-peptide ratios were confirmed using unpaired t-tests. P-values
below 0.05 indicating a relevant difference between the populations of NDs
with and without EDC/NHS-mediated conjugation as well as among the re-
spective oxidation technique for a significance level of 5%. Dry-oxidized NDs
exhibit a higher surface loading compared to wet-oxidized NDs in the case of
the 1:1 ND-peptide ratio. As the ND-peptide ratio increases the surface load-
ing of NDs increases simultaneously starting from under 50% to over 80% of
the bonded peptide. If EDC/NHS was added to the system, the surface load-
ing of NDs increases independently with respect to the employed ND-peptide
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Figure 4.6: (a) Fluorescence spectra for various BMP-2 derived peptide concentrations and (b) calibration
curve (n = 3 and R2 = 0.99785) of the fluorescence intensity as function of the peptide concentration.
ratio. The addition of EDC/NHS enables the possibility to control the surface
loading even at a low ND-peptide ratio and ensure the economical application
of NDs. At surface loadings higher than 80% the discrepancy for as-received
and dry-oxidized NDs is considered as non-significant (P < 0.15). This phe-
nomenon correlates with the maximum surface loading for a 1:1 ND-peptide
mass ratio since steric and hydration repulsion inhibits further peptides to ap-
proach the ND surface [220]. With an increased amount of NDs and ultimately
covalent binding sites, the surface loading capacity can be enhanced. In the
case of a 5:1 ND-peptide ratio with EDC/NHS activation, the absolute surface
loading was slightly increased with 96 ± 1% for as-received and 95 ± 1% for
dry-oxidized NDs.
Figure 4.7 (b) provides evidence of the EDC/NHS-mediated amide formation
between the BMP-2 derived peptide and NDs. The BMP-2 derived peptide (1)
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shows the typical infrared bands of amide I at 1630 cm-1, amide II at 1540 cm-1,
and amide II’ at 1450 cm-1 [221,222]. Amide I vibration arises mainly from the
stretch vibration νC O and is visible in all samples (1-4), whereas amide II and
amid II’ are depicted in the ND-peptide conjugates (2-3). The visible amide II
(N H) and amid II’ (C N) bands, as well as the increased surface loading in the
case of the EDC/NHS-mediated conjugation, indicate the formation of covalent
compounds between the BMP-2 derived peptide and NDs. In order to confirm
the stability of the ND peptide binding, agglomerate size distribution and zeta
potential measurements have been employed. As-received and dry-oxidized ND
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agglomerates with an initial mean hydrodynamic diameter of 26 ± 2 nm and
34 ± 5 nm at pH = 9 were used to bind the BMP-2 derived peptide. After
the EDC/NHS-mediated conjugation, as-received and dry-oxidized NDs show
an increased mean agglomerate size of 1020 ± 143 nm (as-received NDs) and
100 ± 4 nm (dry-oxidized NDs) with the correlated zeta potential of -11 ± 1 mV
and -33 ± 1 mV, respectively. This increase in the agglomerate size is mainly
attributed to the re-aggregation of the NDs during the sedimentation process
related to sample collection and centrifugation. Hence, as-received NDs are
not stable after conjugation with the BMP-2 derived peptide [194]. Concerning
the high agglomerate size, further separation techniques of unbound peptide
and peptide-conjugated NDs such as cascade centrifugation and dialysis have
to be considered [223, 224]. Additional biocompatible dispersing agents and
different crosslinking approaches are able to improve the outcome of the ND
conjugation [225,226].
4.3 Physisorption of Amoxicillin
In order to conjugated NDs with penicillin antibiotics, a surface modification
method based on electrostatic interactions has been applied. Figure 4.8 shows
the ND surface modification pathway using the cationic polyelectrolyte poly-
diallyldimethylammonium chloride (PDDA) and amoxicillin. Whereby, amoxi-
cillin is a broad-spectrum β-lactam antibiotic and prevents the biofilm forma-
tion on biomaterials [227]. These biofilms have great significance for public
health since they are usually pathogenic in nature and can cause nosocomial
infections [228]. Once the biofilm-associated microorganisms are attached to
the biomaterial, their susceptibility to antimicrobial agents is dramatically de-
creased [229]. Therefore, antimicrobial surfaces are highly desirable [230,231].
As-received NDs were modified consecutively by PDDA and amoxicillin. The
resulting surface loading of the ND-PDDA complexes with amoxicillin has been
determined using ultraviolet-visible (UV/Vis) spectroscopy. Figure 4.9 displays
the UV/Vis measurements of amoxicillin, the correlated calibration curve, and
the surface loading of amoxicillin on the ND-PDDA complexes. Figure 4.9 (a)
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Figure 4.8: Conjugation of NDs with amoxicillin using electrostatic attraction.
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exhibits two peaks at 273 nm and 279 nm in the UV/Vis spectra, where both are
correlated with the absorbance of amoxicillin [232,233]. Figure 4.9 (b) displays
the respective calibration curve, which shows a high coefficient of determination
with 99.557%. Accordingly, the UV/Vis absorbance of amoxicillin in the range
of 257-289 nm was used to determine the surface loading. In order to increase
the reliability of the obtained outcome, the area underneath the respective peak
of the UV/Vis spectra has been processed [234]. The amount of the loaded
amoxicillin was calculated by subtracting the concentration of the unbound
amoxicillin from the initial concentration. Figure 4.9 (c) presents the surface
loading of amoxicillin on ND-PDDA complexes, where 440 ± 0.54 µg/ml and
215 ± 0.47 µg/ml of amoxicillin were loaded onto 1 mg/ml and 0.5 mg/ml of
NDs after 1 h of incubation, which corresponds to a surface loading of 44 ± 0.1%
and 43 ± 0.1%, respectively. No influence of the utilized absolute concentrations
on the surface loading was observed due to a constant 1:1 concentration ratio.
After 9 days of incubation, 382 ± 1 µg/ml and 194 ± 1 µg/ml were loaded onto
the respective concentration of ND-PDDA complexes. The longer incubation
time of 9 days does not increase the surface loading of amoxicillin and results
in a 9-13% lower amount of tethered amoxicillin compared to ND-PDDA com-
plexes incubated for 1 h. This significant difference is associated with the dis-
sociation of amoxicillin in aqueous solutions, where 70% of amoxicillin remains
active at pH of 7.0 after 24 h [235]. The maximum surface loading of 44% was
reached after 1 h, and no further molecules were able to reach the surface due
to steric and hydration repulsion [220]. Lee et al. reported surface loadings of
65% for 5:2 ND-amoxicillin and 70% for 5:3 ND-amoxicillin ratio, which de-
scribes a 1.6 to 2.0-fold higher ratio of NDs to antibiotics as employed in the
present thesis [117]. Despite the relatively low surface loadings of 38-44%, the
lowest concentration of amoxicillin loaded onto ND-PDDA complexes remains
higher than the minimum inhibitory concentration for E. coli with 2 µg/ml and
S. aureus with 0.12 µg/ml [236].
4.4 Conclusions
Within this Chapter, the oxidation and a subsequent bioconjugation of NDs are
discussed. NDs have been oxidized to increase the number of oxygen-containing
surface groups. The surface groups were investigated using absorption spec-
troscopy. Afterward, the NDs were loaded with a growth factor (BMP-2 derived
peptide) and an antibiotic (amoxicillin), respectively. Biomolecules were grafted
onto NDs using physisorption and chemisorption, where the respective surface
loading has accordingly been determined. The main findings are:
• The surface chemistry of as-received, wet-, and dry-oxidized NDs is similar,
where each ND modification possesses sp2 carbon (C C), O H, C O, and
C O compounds.
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• Dry oxidation (air annealing at 415 °C for 5 h) maintains the core diamond
crystal structure.
• The highest number of carbonyl compounds was observed for dry-oxidized
NDs. The wet oxidation increased the number of carboxylic acids, whereas
dry oxidation led to the conversion into acid anhydrides on the ND sur-
face → Dry-oxidized NDs are recommended for the EDC/NHS-mediated
conjugation.
• BMP-2 derived peptide was covalently grafted onto as-received and dry-
oxidized NDs using EDC/NHS as crosslinkers.
• Fluorescence spectroscopy has been conducted to determine the surface
loading of NDs with the BMP-2 derived peptide.
• Application of EDC/NHS, various ND-peptide ratios, and the number of
available functional surface groups affected the surface loading of NDs.
– EDC/NHS enabled high surface loadings (over 80%) at low ND-peptide
ratios.
– 5:1 ND-peptide ratio showed the highest surface loadings of 96%.
– Dry-oxidized NDs bound significantly more peptides without EDC/NHS
compared to as-received NDs.
– Surface loadings over 80% led to a non-significant difference between
the binding efficiency of dry-oxidized and wet-oxidized NDs → No
influence of the ND surface chemistry on the peptide-binding at high
ND surface coverages.
• Amoxicillin was grafted onto ND-PDDA complexes using electrostatic at-
traction and the resulting surface loading has been determined using UV/Vis
spectroscopy.
– Maximum of 440 µg amoxicillin per 1 mg NDs (equals 44% surface
loading) was obtained → Minimum inhibitory concentration for E. coli
and S. aureus was achieved.
– Time-dependent stability of the ND-PDDA-amoxicillin complexes in H2O
has been observed due to the degradation of amoxicillin.

5 Coatings Exhibiting Detonation Nanodiamonds
Detonation nanodiamonds (NDs) have been immobilized on biomaterials to fab-
ricate nanostructured and homogenous coatings. First, Section 5.1 discusses the
colloidal stability of aqueous ND suspensions in a broad pH range and explains
the influence of the ion concentration. Section 5.2 describes the electrophoretic
deposition and the covalent attachment of NDs on commercially pure grade 4 Ti.
Subsequently, Section 5.3 outlines the polyelectrolyte multilayers (PEMs) con-
taining NDs. PEMs show the possibility to control the resulting yield of immobi-
lized NDs and the roughness of the final coating.
5.1 Colloidal Stability of Aqueous ND Suspensions
In order to maximize the surface area of NDs and to obtain homogeneous coat-
ings, the colloidal stability of NDs at various pH has been assessed. The pH of
the surrounding solution is a dominating environmental factor that influences
the colloidal stability of a suspension. Like ionic strength, the colloidal stability
at a given pH depends on the chemical profile of the NDs with functional sur-
face groups exhibiting a range of acid dissociation constant (pKa) values [191].
Colloids tend to be stable, provided the magnitudes of their associated zeta po-
tentials are greater than |30| mV. As the potential drops below 30 mV, forces
due to dispersion begin to dominate over Coulomb repulsion, as described by
the theory of Derjaguin, Landau, Verwey, and Overbeek [190].
5.1.1 ND Agglomerate Size and Zeta Potential Measurement
In order to obtain a high surface-to-volume ratio, which is necessary both for
homogeneous coatings and for an efficient ND functionalization, stable suspen-
sions with the tiniest achievable ND agglomerate size were identified. The dis-
aggregated ND suspensions were obtained using bead milling and salt-assisted
ultrasonic deaggregation (SAUD) of the as-received NDs. Figure 5.1 displays the
mean hydrodynamic diameter of bead-milled and as-received ND suspensions in
the pH range from 3.0 to 14.0 as well as the correlated zeta potential.
The outcome of the SAUD-treated ND suspensions is not shown since the
obtained data represent a similar trend compared to bead-milled NDs with
a non-significant difference in the hydrodynamic diameter and zeta potential
(P > 0.05, unpaired t-test). Figure 5.1 (a) exhibits the agglomerate size distri-
bution and the zeta potential of the as-received ND suspensions for a shifting
pH. The hydrodynamic diameter of the as-received ND agglomerates remains
constantly above 200 nm for 4.0 < pH < 13.0 with the smallest mean hydro-
dynamic diameter of 237 ± 127 nm. Additionally, the zeta potential varies
between -50 mV and -35 mV forming stable suspensions, which is related to
the deprotonation of the functional ND surface groups within the pH range.
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Figure 5.1: Agglomerate size distribution and zeta potential measurements of (a) as-received and (b)
bead-milled aqueous ND suspensions at different pH. ND concentration = 1 mg/ml.
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The amino groups of NDs are protonated at pH < 4.0 resulting in the more
positive zeta potential of larger agglomerates and NDs flocculate at pH > 13.0
due to a shielding effect of the negatively charged ND surface groups by Na+
ions [237,238].
Figure 5.1 (b) shows a clear trend in the agglomerate size distribution and
the zeta potential of bead-milled ND suspensions. As indicated by the purple
arrows, the zeta potential starts to increase at pH > 4.0 and pH > 10.0, where
the mean diameter of ND agglomerates decreases simultaneously. The increase
in the zeta potential at pH > 4.0 is correlated with the deprotonation of car-
boxylic acids. Afterward, the zeta potential and the ND agglomerate size are
on a consistent level until pH = 10.0, where the hydroxyl groups start to de-
protonate. Zheng et al. described the deprotonation of hydroxyl groups in an
alkaline environment as part of a Williamson etherification [154]. The ND sus-
pensions with pH > 12.0 start to flocculate as previously described in the case
of as-received ND suspensions. The ND suspension possessing pH = 12.0 proves
to be the most stable, with a mean agglomerate size of 43 ± 17 nm and a zeta
potential of 71 ± 5 mV.
Figure 5.2 displays the correlated transmission electron microscopy (TEM)
images of ND agglomerates after bead milling. The single ND particles are in
the range of 5-7 nm and the ND agglomerate size is ∼ 40 nm. The ND ag-
glomerate size obtained from TEM imaging compares to the outcome of the
dynamic light scattering measurements. The black dots in Figure 5.2 (a) refer
to impurities originating from the bead milling process. These ZrO2 contam-
inations are difficult to remove and require additional treatment with strong
acids or bases [239]. Concentrated alkali is expected to remove the ZrO2 con-
taminations and also the fragmented amorphous carbons generated during the
bead milling process, though the treatment could lead to the re-agglomeration
of NDs [183].
25 nm
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a
Figure 5.2: Transmission electron microscopy images of (a) single ND particles, which tend to agglomer-
ate, and (b) a ND agglomerate both after bead milling.
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5.1.2 Influence of pH and Ion Concentration
The agglomeration behavior of the as-received and bead-milled ND suspensions
will be discussed using the model of NDs, which merely possess oxygen-contain-
ing surface groups, as displayed in Figure 5.3.
NDs provide miscellaneous oxygen-containing surface groups including acid
anhydrides, carboxyl, and hydroxyl groups [190]. These surface groups tend
to form hydrogen bonds, which leads to a robust agglomeration behavior of the
NDs (see Subsection 2.4.3). However, an increasing ion concentration of the sus-
pension will alter the functional surface groups of NDs. The pH of 5.0 represents
the starting point of the NaOH titration. Based on the Henderson-Hasselbalch
equation, the ratio of ionized and non-ionized acid is one when the pH equals
the pKa, where the pKa of carboxylic acids such as acetic acid, propionic acid,
and valeric acid is 5.0 [240]. In the beginning, approximately 50% of the car-
boxylic acids on the ND surface are deprotonated, which explains the high col-
loidal stability of ND suspensions at that point. As the pH increases, the ND
surface groups gradually lose protons due to the electrolytic dissociation in the
presence of proton acceptors and the zeta potential increases. The ND agglom-
erates become smaller and Na+ ions electrostatically interact with the deproto-
nated surface groups. All oxygen-containing surface groups are deprotonated at
a pH of 12.0, where the zeta potential and the ND agglomerate size are of its
smallest.
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Figure 5.3: The model of the ND surface chemistry under NaOH titration.
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No further dissociation of oxygen-containing surface groups is evident at pH
over 12.0 and the prevalent Na+ ions are shielding the negatively charged ND
surface groups [238]. The charge density is low, and repulsive forces between
NDs are humble, leading to irreversible agglomeration. The further increase in
pH does not improve the stability significantly, because the ND agglomerates are
too large to form colloidal suspensions [194]. Moreover, the ND surfaces are am-
photeric, which means they have acidic and basic centers coexisting on their sur-
faces, which can result in positively charged ND agglomerates at high pH [190].
Aleksenskiy et al. described a similar phenomenon of ND re-agglomeration in
presence of Fe2+ ions through bridge bonding formations [177]. Since sodium
ions are monovalent, they cannot create bridge bonds such as divalent Fe2+ ions.
However, increasing the ionic strength of the suspension medium (pH > 12.0)
increases the measured ND agglomerate size. The electrical double layer theory
explains a reduction in the thickness of the diffuse double layer with increasing
ionic strength. This allows for a greater degree of particle-particle interaction
resulting in an increase in the level of agglomeration and potential for ND set-
tling [241,242]. Similar colloidal stability of initially negatively charged NDs at
high Na+ ion concentration was observed from Gibson et al. [194].
The presented model explains the mechanism of the decreased zeta poten-
tial at high ion concentrations by dissociative processes of the functional ND
surface groups. The as-received ND suspensions are a notable exception to the
proposed model, where no trend in agglomerate size and zeta potential is iden-
tifiable. The initial higher agglomerate size of the as-received NDs translates in
a lower available surface and less functional groups compared to suspensions
with smaller ND agglomerates. Therefore, the effect of the Na+ ions is reduced
and the electrostatic interactions are not able to break the agglomerates of the
as-received NDs.
5.2 Electrophoretic Deposition and Covalent Attachment
The current thesis aims to develop different coating strategies of biomaterials by
the use of NDs. NDs have previously been applied in tissue engineering applica-
tions due to their functionalization capabilities. Therefore, polymeric scaffolds
were modified via physisorption of BMP-2 functionalized NDs to facilitate the
bone formation in vitro [119]. Additionally, physisorbed monolayers of NDs
promote the formation of functional neuronal networks bypassing the neces-
sity of protein coatings [243]. In order to achieve a homogeneously dense and
nanostructured ND coating of commercially pure (cp) grade 4 Ti, three differ-
ent coating strategies were studied using topographic investigation methods.
Figure 5.4 shows the scanning electron microscopy (SEM) and atomic force mi-
croscopy (AFM) images of Ti substrates possessing NDs on their surfaces. The
ND clusters on Ti are highlighted by white arrows.
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Figure 5.4: Scanning electron microscopy and atomic force microscopy images of ND coatings on Ti. (a)
Untreated Ti, (b) physisorbed NDs, (c) electrophoretically deposited NDs, and (d) covalently attached NDs.
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NDs were immobilized using dip coating, electrophoretic deposition (EPD),
and a covalent attachment strategy. The covalent attachment strategy is based
on an amide formation between a silanized Ti substrate and oxidized NDs (see
Section 3.4). Figure 5.4 (a) exhibits the untreated Ti substrate. Figure 5.4 (b)
illustrates the physisorbed NDs, which were immobilized via dip coating. Fig-
ure 5.4 (c) shows the NDs, which were electrophoretically deposited, and Fig-
ure 5.4 (d) displays the covalently attached NDs on the Ti substrates. The sur-
face inhomogeneities in the images are related to the polishing process.
The ND clusters formed via physisorption (dip coating) are less dense com-
pared to ND clusters yielded via EPD and covalent attachment. The EPD leads
to surfaces with a higher ND density due to the homogeneously applied elec-
tric field during the coating process. In both cases, EPD and dip coating cause
a loose attachment of the NDs, where the attachment is based on electrostatic
attractions and van der Waals interactions. The highest immobilization rate
and density of NDs were achieved using amide-linkages between Ti and NDs.
The covalent attachment strategy requires oxidized NDs and amine-terminated
silanized surfaces. The agglomerates of carboxylated NDs are larger due to their
higher number of functional carboxylic acid surface groups and the resulting
tendency of hydrogen bonding, which furthermore explains the observed dense
ND clusters on the substrates [179]. In order to promote the ND yield and the
ND distribution on the Ti substrates, the combination of the covalent attachment
strategy and EPD is favorable. Overall, the covalently attached NDs provide the
best outcome in terms of reproducibility with homogeneous and almost total Ti
surface coverage.
In order to assess the attachment of the immobilized NDs, nanoindentation
measurements were carried out on planar Si as reference material, to avoid
the influence of the surface inhomogeneities of the previously discussed Ti sub-
strates. Figure 5.5 illustrates the adhesion strength of the NDs to the surface,
using the direct determination of the lateral force to move the indentation tip
and ND agglomerates, respectively.
The displayed graphs describe the movement of the nanoindentation tip on
the surface and exhibit the lateral force as a function of lateral displacement.
Figure 5.5 (a) demonstrates the measurements for the bare Si. The lateral force
increases following the direction of the tip. For both ND-coated samples, sharp
peaks (black arrows in Figure 5.5 (b) and (c)) in lateral force were detected,
with greater variations for the covalently attached NDs than for the surface pos-
sessing physisorbed NDs. Intense force jumps were observed during the lateral
displacement of the tip, moving along the sample of covalently attached NDs,
where larger ND agglomerates exert higher forces on the nanoindentation tip.
In the resistance of the ND agglomerates opposing the moving tip, clear differ-
ences are observable. Covalently attached NDs exhibit 60% higher lateral forces
compared to physisorbed NDs. The ND adhesion of dip-coated Si samples are
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Figure 5.5: The lateral force as a function of the lateral displacement of the indentation tip for (a) uncoated
Si, (b) NDs physisorbed, and (c) NDs covalently attached to Si.
based on physisorption, mainly caused by limited van der Waals force and elec-
trostatic interactions, whereas covalently attached (chemisorbed) NDs possess
stable amide compounds to the substrate. Every peak in the lateral force is likely
to be associated with a single ND agglomerate resisting the movement of the tip.
The sharp peaks in lateral force appear as the tip either skips or completely de-
taches from the same agglomerate.
Nanoindentation measurements provide a first means of comparison for the
adhesion strength of differently immobilized ND agglomerates [244]. Cova-
lently attached ND agglomerates pose a higher resistance to the tip movement,
confirming that the interaction of NDs with the substrate is more robust com-
pared to the physisorbed NDs. In addition, AFM measurements can be con-
ducted to asses the adhesion strength and the nanotribology of nanoparticles on
macroscopic surfaces. AFM revealed that the functional surface groups of ph-
ysisorbed Au nanoparticles influenced their adhesion strength to Si [245]. Au
nanorods and nanoparticles physisorbed on Si reduced the coefficient of friction
due to a reduced contact area [246]. Furthermore, the shape of Au nanoparti-
cles is critical for their adhesion and friction [247].
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5.3 Polyelectrolyte Multilayers
Drug-eluting coatings combining common coating technologies with nanopar-
ticulate carriers are a promising pathway to release pharmaceuticals locally and
consequently enhance the effectiveness as well as selectivity of the applied drug
molecules [248, 249]. The release of drugs can be controlled by (1) degra-
dation of the coating, (2) diffusion due to a porous structure of the coating,
and (3) solution flow based on dedicated drug reservoirs from the surface of the
coating [250]. Polyelectrolyte multilayers (PEMs) are able to address both diffu-
sion and degradation controlled release of drugs based on the applied polyelec-
trolytes [251,252]. Potential release mechanisms are the photocatalytic decom-
position, application of biodegradable polyelectrolytes, or dissociation based on
the local alteration of physiological salt concentration and pH in human body
fluids [253–255]. Dierich et al. characterized PEMs utilizing growth factors and
showed the osteogenic differentiation of stem cells induced from the released
biomolecules [256]. However, NDs as drug delivery vehicles show the possibil-
ity for a more controlled in vivo release of the biomolecules. NDs have been
investigated earlier as delivery platforms for growth factors to promote bone
formation [257]. PEMs have been applied in the present thesis to control the
density and yield of immobilized NDs on macroscopic surfaces.
Figure 5.6 exhibits ND-polydiallyldimethylammonium chloride (PDDA) mul-
tilayers on silica glass consisting of negatively charged ND agglomerates and the
positively charged polyelectrolyte PDDA. Accordingly, Figure 5.6 (a) and (d) de-
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Figure 5.6: (a)-(c) Scanning electron microscopy and (d)-(f) atomic force microscopy images of ND-PDDA
multilayers on silica glass. (a)+(d) Bare silica glass, (b)+(e) one bilayer and (c)+(f) five bilayers of NDs
and PDDA.
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scribes the bare silica glass surface without ND-PDDA multilayers. Figure 5.6 (b)
and (e) shows one bilayer while Figure 5.6 (c) and (f) illustrates five bilayers
of NDs and PDDA. The immobilized NDs cover the entire surface in the case
of the employed one and five bilayers. The height of one bilayers ranges from
10-50 nm deduced from AFM measurements. All further applied bilayers are
going to coarsen the roughness based on the initial ND agglomerate size dis-
tribution. Five bilayers of NDs and PDDA form the roughest surface with a
maximum height of 90 nm, and the immobilized NDs are packed closer to each
other compared to one bilayer.
No linear correlation between the acquired ND-PDDA multilayer heights and
the number of applied bilayers was detected. This outcome can be explained
following the space-filling mechanism of PEMs containing nanoparticles [258].
Small ND agglomerates penetrate the existing bilayer and occupy the inter-
spaces of the prevailing ND structures. Hence, the prevalent bilayer of NDs
and PDDA influences the morphology of the following bilayer. The understand-
ing of the ND coating behavior using PEMs is the key to predict the resulting
yield of NDs on macroscopic surfaces and to promote such systems in the di-
rection of drug-eluting coatings. The interactions between the substrate, ND
agglomerates, and polyelectrolytes are based on electrostatic attractions [259].
Furthermore, hydrogen bonding facilitates the formation of PEMs [260]. The
applied polyelectrolyte PDDA belongs to the group of polycations and is able
to interact with the negatively charged ND agglomerates. PDDA is widely used
to modify nanoparticulate carriers and to immobilize nanoparticles on macro-
scopic surfaces [261, 262]. The employed SAUD technique was not capable to
disaggregate the ND agglomerates.The observed ND agglomerate size was larger
compared to the values reporter in the literature, due to a slightly modified pro-
tocol and lower concentrations of NDs utilized during the disaggregation tech-
nique [186]. The absence of chloride in the ND suspensions has been proved
using Mohr’s method and further aggregation due to interactions of NDs with
NaCl ions can be excluded.
5.4 Conclusions
The present Chapter depicts the colloidal stability of NDs and their coating
behavior. The influence of the ion concentration on the ND agglomerate size
distribution and zeta potential has been investigated. NDs have been immobi-
lized using physisorption, electrophoretic deposition, and a covalent attachment
strategy, which requires the silanization of the substrate. In order to control the
yield and roughness of the immobilized NDs, PEMs were utilized. PEMs are
an outstanding technique with several advantages such as self-organization and
universal applicability for different substrates. Moreover, PEMs enable cleavable
NDs due to electrostatic interactions. The main findings are:
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• Aqueous suspensions of as-received and bead-milled NDs remained stable
within 5 < pH < 13, and the smallest ND agglomerates have been obtained
at pH = 12.
• ND agglomerate size and zeta potential within the stability range varied
from 345 ± 133 nm to 237 ± 127 nm and from -40 ± 4 mV to -50 ± 4 mV
for as-received ND suspensions; from 324 ± 173 nm to 43 ± 17 nm and
from -40 ± 5 mV to -71 ± 5 mV for bead-milled ND suspensions.
• As the ion concentration of the ND suspension medium increased, ND sur-
face groups gradually deprotonated, and the correlate zeta potential of NDs
increased equally.
• Dip coating, electrophoretic deposition and covalent attachment of NDs
via silanization are techniques capable to immobilize NDs on macroscopic
surfaces.
– The covalent attachment strategy caused the highest ND density and
surface coverage of the substrate.
– Nanoindentation enabled the assessment of the ND adhesion strength
to the substrate.
• The ND yield and the resulting roughness of immobilized NDs can be con-
trolled using PEMs.
– PDDA enables the formation of ND-PDDA multilayers on macroscopic
surfaces.
– The final roughness of immobilized NDs depended on the number of
applied ND-PDDA bilayers, where five bilayers reached 90 nm in height.
– No linear correlation of the acquired ND-PDDA multilayer heights with
the number of applied bilayers was detected.

6 Biological Assessment of Detonation Nanodiamond Coat-
ings
The detonation nanodiamonds (NDs) conjugated to biomolecules, the biomole-
cules utilized in the surface modification of NDs, and the polyelectrolyte multi-
layers (PEMs) containing NDs were assessed in vitro. Section 6.1 presents the
differentiation of human mesenchymal stem cells (hMSCs). The influence of the
bone morphogenetic protein-2 (BMP-2) derived peptide with the sequence KIP-
KASSVPTELSAISTLYLGGC and its native protein on the cell differentiation has
been examined. Additionally, hMSCs were cultured on Ti substrates possessing a
bilayer of NDs conjugated to the BMP-2 derived peptide and poly-L-lysine (PLL).
Section 6.2 discusses the cellular response of human fetal osteoblasts (hFOBs)
to ND-polydiallyldimethylammonium chloride (PDDA) multilayers. Therefore,
up to five bilayers of NDs and PDDA have been applied to silica glass.
6.1 Alkaline Phosphatase Activity of Mesenchymal Stem Cells
The osteogenic potential of NDs conjugated to the BMP-2 derived peptide and
immobilized via PLL, as well as the untethered biomolecules, has been deter-
mined using the alkaline phosphatase (ALP) activity of hMSCs. The ALP activity
is a very early marker of cell differentiation into the osteogenic lineage [263].
Principally, hMSCs are non-hematopoietic, multipotent stem cells with the ca-
pacity to differentiate into mesodermal lineages such as osteocytes, adipocytes,
and chondrocytes as well as ectodermal (neurocytes) and endodermal (hepato-
cytes) lineages [264].
Figure 6.1 (a) depicts the ALP activity of hMSCs cultured under the addi-
tion of the BMP-2 derived peptide and its native protein. The ALP activity de-
creases from the lower to the higher concentration of BMP-2 derived peptide
added. Accordingly, the highest ALP activity has been obtained in the case of
no biomolecules added. The addition of the native BMP-2 causes the lowest
ALP activity, even though it is a well-established growth factor inducing osteo-
genesis in mesenchymal progenitor cells [265]. However, the ALP activity rises
upon the application of the osteogenic medium for all groups compared to cells
cultured in growth medium. Figure 6.1 (b) exhibits the ALP activity of hMSCs
cultured on plain Ti and Ti with differently functionalized ND-PLL bilayers. The
hMSCs cultured in osteogenic medium on ND-PLL bilayers show a higher ALP
activity compared to cells cultured in growth medium on plain Ti. The ALP ac-
tivity tends to decrease with the increasing number of functional surface groups
of NDs, starting from as-received NDs, oxidized NDs, and NDs possessing the
BMP-2 derived peptide (ND+peptide).
The present thesis supports the outcome of Tirkkonen et al., where the os-
teogenic medium had a higher impact on the differentiation of human adi-
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Figure 6.1: ALP activity of hMSCs cultured for seven days in growth medium (GM) or osteogenic medium
(OM) on (a) polystyrene under the addition of the respective biomolecule and (b) differently functionalized
NDs in ND-PLL bilayers on Ti. Statistical relevance n = 1.
pose stem cells compared to common growth factors. Additionally, the em-
ployed BMP-2 showed a non-significant influence on cell differentiation [266].
Mizuno et al. reported that BMP-2 failed to increase the ALP activity of hMSCs,
whereas the dexamethasone containing medium increased the ALP activity in
the same cell line [267]. Although the mechanism behind the inducing abili-
ties of dexamethasone is unclear, it has been shown to enhance the response
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of murine MSCs to the osteogenic abilities of BMP-2 in vitro [268]. BMP-2 pro-
motes the differentiation of osteoprogenitor cells and induce osteogenesis in
MSCs from rats and mice. However, compared to results with animal mod-
els, BMP-2 is relatively inefficient in inducing hMSCs to undergo osteogenesis,
and there is no evidence that BMP-induced signaling directly regulates alkaline
phosphatase gene transcription [269]. Diefenderfer et al. performed similar in-
vestigations with hMSCs and studied the effect of BMP-2, -4, and -7. The study
reports a non-significant osteogenic response in terms of ALP activity, but re-
vealed elevated levels of different osteogenic markers like bone sialoprotein and
osteopontin, which were successfully induced from the BMPs [270]. Moreover,
a profiled addition of BMP-2 is known to increase the osteocalcin release from
murine MSCs [271]. MSCs within their native environment of the stem cell
niche in bone receive biochemical stimuli from surrounding cells. The role of
the natural cues from osteocytes and osteoblasts in regulating the osteogenic
differentiation of MSCs in vivo is unclear, suggesting a co-culture model for
further investigations [272]. Despite the discussed factors of the BMP-2 influ-
ence on the ALP activity, the obtained lower ALP activity of hMSCs cultured
on ND-PLL bilayers might be attributed to the ND agglomerate size. The more
distinct nanotopography and low nanoroughness of as-received ND-PLL bilay-
ers alter the cell signaling, which results in a higher ALP activity. Rosa et al.
reported a significantly higher ALP activity on Ti substrates with nanoscale sur-
face features compared to smooth Ti substrates [273].
6.2 Cellular Response of Osteoblasts
Nanoparticle-enhanced coatings of bone implants are a promising pathway to
improve the patient’s well-being and to facilitate sustainable wound healing
[274–276]. The following Subsections discuss the in vitro cell response of os-
teoblasts to ND-PDDA multilayers as a novel class of carbon-based coating ma-
terials comprising a unique combination of high biocompatibility and superior
drug-binding properties. Figure 6.2 summarizes the conducted cell experiments.
The hFOBs cultured on ND-PDDA multilayers show a high amount of vinculin
studied via quantitative fluorescence imaging analysis. The influence of the
surface roughness on the filopodia formation has been assessed. The high bio-
compatibility of the ND-PDDA multilayers, indicated via high cell proliferation
and sound cell adhesion, shows their potential for biomedical applications such
as drug-eluting coatings and biomaterials in general.
6.2.1 Cell Morphology
Cell morphological changes provide important information about cell differen-
tiation processes, cell functions, and signal responses [277]. The morphology
of adherent hFOBs has been assessed by the extent of the cell spreading ob-
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Figure 6.2: Schematic representation of the hFOB cultivation on ND-PDDA multilayers.
tained via fluorescence microscopy and scanning electron microscopy (SEM).
Figure 6.3 displays the calculated mean area of the adherent cells and the corre-
lated merged fluorescent microscopy images. The mean cell area, the shape of
the cytoskeleton, and the distribution of cells, which were cultured on ND-PDDA
multilayers and silica glass with fibronectin (FN) coating, are comparable. As
shown in Figure 6.3 (a), the difference in the mean area of adherent cells on one
bilayer and five bilayers of NDs and PDDA is non-significant compared to silica
glass with FN coating. The mean area of adherent cells on the silica glass with
FN coating is 2040 ± 800 µm2, one bilayer 1460 ± 630 µm2, and five bilayers
1060 ± 650 µm2. This outcome correlates with the representative fluorescence
microscopy images displayed in Figure 6.3 (b) - (d). The hFOBs cultured on
ND-PDDA multilayers and silica glass with FN coating demonstrate a compara-
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Figure 6.3: (a) Mean area of adherent hFOBs on the respective surface modification. Unpaired t-test
(n = 3) *P > 0.05; **P < 0.01. Merged fluorescence microscopy images of hFOBs on (b) silica glass
(with FN coating), (c) one bilayer, (d) five bilayers of NDs and PDDA, and (e) a monolayer of PDDA. Scale
100 µm; red - F-actin, blue - cell nuclei, green - vinculin.
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ble shape and spreading behavior using fluorescence microscopy. In contrast,
Figure 6.3 (e) depicts the hFOBs cultured on a monolayer of PDDA, which ex-
hibit a discrepancy in the mean cell area and cell shape compared to cells cul-
tured on ND-PDDA multilayers and silica glass with FN coating. The complex
actin network and focal adhesions, which are associated with the vinculin con-
tent, are indiscrete and coinciding in the images [278]. The hFOBs cultured on
a monolayer of PDDA try to minimize their surface, which results in a minimal
mean area of the adherent cells of 520 ± 30 µm2.
In order to compare the morphological changes of hFOBs on ND-PDDA mul-
tilayers, SEM imaging has been conducted. Figure 6.4 exhibits the correlated
SEM images of the filopodia formation and the differences of the adherent
hFOBs along the nanoroughness that is rather randomly distributed. Filopodia
are highly dynamic cell-surface protrusions used by cells to sense their exter-
nal environment [279]. The hFOBs on one bilayer exhibit a larger number of
thicker filopodia, which grew in a straighter direction, whereas those on five
layers avoid large ND agglomerates, as highlighted in Figure 6.4 (a) and (b).
The red arrows indicate the filopodia, which were able to pass over the ND ag-
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Figure 6.4: Scanning electron microscopy images of the hFOB filopodia grown on (a)+(c) one bilayer and
(b)+(d) five bilayers of NDs and PDDA for 24 h. Scale of insets 1 µm.
64 6 Biological Assessment of Detonation Nanodiamond Coatings
glomerates of one bilayer, and the yellow arrows highlight that the filopodia
were either blocked or avoided by the large ND agglomerates of five bilayers.
The increase in the nanoroughness inhibits the filopodia formation and disturb
the communication between cells living close to each other. Figure 6.4 (c) and
(d) displays the overview of cultured hFOBs, where the cells on the less rough
surfaces of one bilayer form a higher number of defined filopodia compared to
five bilayers of NDs and PDDA.
The mean area of adherent hFOBs tends to decrease on five bilayers com-
pared to one bilayer of NDs and PDDA. The reduced spreading of the cells
can be explained by comparing the filopodia formation on the ND-PDDA mul-
tilayers possessing different surface roughnesses. Filopodia play an important
role in sensing topography and are associated with cell spreading and migra-
tion [280, 281]. The growth and extension of filopodia are reduced on five
bilayers of NDs and PDDA with a high surface roughness, which can be under-
stood as the relative decrease in cell spreading and migration. On the other
hand, filopodia can grow on one bilayer and are not affected by the surface fea-
tures due to the smaller ND agglomerates. The degree of filopodia formation
appears to be highly dependent on the height of the ND agglomerates. This
outcome agrees with previous reports that filopodia formation was extensively
limited in regions with higher roughnesses [282]. Biggs et al. described that a
70-100 nm height of protrusion reduced the cell adhesion and the focal adhesion
complex formed again when the height was under 50 nm [283]. However, cells
cultured on ND-PDDA multilayers exhibit a similar cell shape and cytoskeletal
organization compared to silica glass with FN coating, suggesting that cells pos-
sess undisturbed signal transduction pathways and ultimately comparable cell
health [284].
6.2.2 Cell Adhesion
The cell adhesion is the initial phase for vital cell activity and conclusively in-
fluences the development of the tissue [285–287]. In order to compare cell
adhesion on different surfaces, the expression level of vinculin was measured by
quantitative fluorescence imaging analysis [288]. Vinculin is a protein that con-
stitutes the integrin-mediated focal adhesion and can be compared to assess the
direct cell contact [289]. Moreover, the formation of the cell adhesion complex
via vinculin is related to a biochemical attachment of hFOBs, which furthermore
suggests that the substrate possesses high biocompatibility [285].
Figure 6.5 illustrates the mean intensity of vinculin per cell and the corre-
lated surface area of the ND-PDDA multilayers. The mean vinculin intensity of
hFOBs cultured on one bilayer and five bilayers of NDs and PDDA are slightly
increased compared to silica glass with FN coating, possessing total values of
104 ± 20% and 107 ± 16%, respectively (Figure 6.5 (a)). The difference in the
mean vinculin intensity is non-significant. On the contrary, the mean vinculin
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Figure 6.5: (a) Mean intensity of vinculin per cell in percent of the control for one bilayer and five bilayers
of NDs and PDDA after 24 h of incubation. Welch’s unpaired t-test (n > 30) *P > 0.05; **P < 0.01. (b)
Surface area of ND-PDDA multilayers; reference area for measurement 100 µm2.
intensity decreases to a total value of 74 ± 17% in the case of silica glass without
FN coating, which represents a significantly lower amount of vinculin compared
to the ND-PDDA multilayers. This outcome confirms that ND-PDDA multilay-
ers promote the adhesion of hFOBs to a similar extent as substrates with FN
coatings. FN is part of the extracellular matrix and contains tripeptide arginine-
glycine-aspartic acid, a motif mediating cell adhesion [290]. It is known from
the literature, that amine-terminated NDs promote neuronal cell adhesion, pro-
liferation, and neurite outgrowth [291]. Additionally, various ND coatings uni-
versally promote the cell adhesion of murine hippocampal neurons [292].
The surface area is one of the key parameters that affect the extent of bind-
ings for cell adhesion [293]. The nanotopography of the ND-PDDA multilay-
ers increases the real and accessible surface area. Figure 6.5 (b) shows the
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increase in the surface area along with the iteration of PEMs. The geomet-
rical reference area was 10 µm x 10 µm. The surface areas of one bilayer
and five bilayers are increased by 2.5% and 5% compared to silica glass with
FN coating. The underlying nanoroughness affects the cell adhesion as the
surface features provide anchorage to focal adhesions [294]. Therefore, the
surface area is correlated with the mean vinculin intensity [295]. The non-sig-
nificantly highest vinculin content was observed for five bilayers of NDs and
PDDA, which revealed, at the same time, the largest surface area. In general,
osteoblasts form more focal adhesions on smooth compared to nanorough and
nanogrooved surfaces [296]. The surface area represents the main driving force
that actively influences adhesion, development, and functionality of human neu-
roblastoma cells, where the cell attachment decreased on nanostructured com-
pared to smooth Au substrates [297]. Additionally, epithelial cells and human
bone cells showed fewer and smaller focal adhesions on rough compared to
smooth Ti substrates [298,299].
6.2.3 Cell Viability
The biocompatibility of the ND-PDDA multilayers has been assessed using the
metabolic cell activity and cell density of hFOBs. The determination of the cell
viability is broadly used to define the in vitro biocompatibility of various mate-
rials [300, 301]. Figure 6.6 illustrates the cell viability of hFOBs in percentage
compared to silica glass with FN coating, the correlated substrate roughness,
and the cell density of hFOBs. Figure 6.6 (a) shows the cell viability of hFOBs
cultured on ND-PDDA multilayers and on a monolayer of PDDA after 24 h of in-
cubation. Once the hFOBs are exposed to the ND-PDDA multilayers, the cell via-
bility increases to a total value of 143 ± 67% for one bilayer and 101 ± 61% for
five bilayers in comparison to silica glass with FN coating. The difference in cell
viability between the populations of ND-PDDA multilayers and silica glass with
FN coating are non-significant. Accordingly, the ND-PDDA multilayers possess
the same biocompatibility as FN-coated substrates. Since the applied PEMs con-
sist of NDs and PDDA, the influence of PDDA on the viability of hFOBs has been
investigated. PDDA leads to a significantly lower cell viability with 12 ± 6% of
living hFOBs compared to silica glass with FN coating. Figure 6.6 (b) exhibits
the correlated roughness values Rq for the respective surface modification. Five
bilayers of NDs and PDDA provide the highest roughness value of 43 ± 4 nm,
whereas one bilayer shows a lower roughness values of 25 ± 5 nm. The lowest
roughness was obtained from silica glass with FN coating possessing an Rq of
1.3 ± 0.1 nm. Figure 6.6 (c) shows the cell density of hFOBs on each substrate
after 24 h of incubation using optical microscopy image analysis. The number of
adhered hFOBs on ND-PDDA multilayers decreases compared to the number of
cells on silica glass with FN coating. The difference in the cell density between
one bilayer and five bilayers of NDs and PDDA is non-significant.
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Figure 6.6: (a) Cell viability in percent of hFOBs cultured on ND-PDDA multilayers and on a monolayer
of PDDA after 24 h of incubation. (b) Surface roughness Rq in nm and (c) cell density of adherent hFOBs.
Unpaired t-test (n = 6) *P > 0.05; **P < 0.01.
The ND-PDDA multilayers exhibit high biocompatibility. The cell viability of
hFOBs cultured on ND-PDDA multilayers was over 100% in comparison to sil-
ica glass with FN coating. Moreover, the hFOBs showed non-significant higher
cell viability in the case of one bilayer compared to five bilayers of NDs and
PDDA, which correlates with the observed filopodia formation and the surface
roughness of the substrates. Substrates with a high nanoroughness lead to re-
duced proliferation of osteo- and fibroblasts [302,303]. Furthermore, the higher
amount of PDDA in the case of five bilayers may results in lower cell viability due
to the dose-dependent cytotoxic character of the polyelectrolyte [304]. Accord-
ingly, the hFOBs cultured on a monolayer of PDDA try to minimize their surface,
leading to significantly smaller mean cell areas, the smallest number of adherent
cells, and low cell viability. The cell behavior on various surface modifications
strongly depends on several factors such as surface chemistry, surface feature
sizes, cultivation period of the cells, and cell lineage [305, 306]. However,
Xu et al. showed the higher cell adhesion of fibroblasts on positively charged
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surfaces compared to their negatively charged counterparts and discussed the
influence of the underlying topography [307]. The present outcome suggests
that negatively charged and nanostructured surfaces are favorable for hFOBs
compared to positively charged and smooth surfaces. At the same time, the
highest number of adherent hFOBs was observed for silica glass with FN coat-
ing due to its high affinity for cell adhesion. Despite the high cell viability of
hFOBs cultured on ND-PDDA multilayers, they exhibit the smallest number of
adherent cells. In order to improve the significance of the obtained results, the
performance of long-term proliferation assays is proposed [308].
Further investigations related to the translational relevance and the release
kinetics of peptide-conjugated NDs have to be addressed concerning their spe-
cific application. The advantages of the ND-PDDA multilayers are the high flexi-
bility of the employed PEMs regarding the substrate material and the possibility
to create multifunctional surfaces. The disadvantages are the currently applied
polyelectrolyte, namely PDDA, and the insufficient understanding of the influ-
ence of the surface charge on the cellular response [309]. However, a monolayer
of negatively charged NDs cancels the cytotoxic effect of the positively charged
polyelectrolyte PDDA. Consequently, ND-PDDA multilayers are considered as
biocompatible material suitable for biomedical applications, especially for bone
implants.
6.3 Conclusions
The biocompatibility of ND-PDDA multilayers and the bone regeneration capa-
bility of peptide-conjugated NDs have been discussed within the present Chap-
ter. The in vitro characterization of the biological performance is the key to
address the translational relevance of NDs and to predict their efficiency in clin-
ical trials. In order to promote bone formation and to influence the cell dif-
ferentiation of hMSCs, NDs have been conjugated to a BMP-2 derived peptide.
The osteoprogenitor marker ALP has been assessed to evaluate the osteogenic
potential of the peptide-conjugated NDs.
The cell morphology, cell adhesion, and cell viability of hFOBs on ND-PDDA
multilayers have been investigated. The ND-PDDA multilayers possess high bio-
compatibility assessed using the analysis of the hFOB viability. Additionally,
the hFOBs adhere to ND-PDDA multilayers to the same extent as on FN-coated
substrates. Despite the high vinculin content of hFOBs cultured on ND-PDDA
multilayers, the adherent cells exhibit a similar mean area and a smaller num-
ber compared to cells cultured on silica glass with FN coating. This behavior
is related to the nanoroughness of the substrates, which accordingly influences
the filopodia formation of hFOBs. The outcome proves the feasibility of NDs as
a coating material for biomedical applications and as promising drug delivery
vehicles. The main findings are:
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• Cellular response of hMSCs to the BMP-2 derived peptide and its native
protein.
– ALP activity of hMSCs decreased from the lower to the higher concen-
tration of BMP-2 derived peptide added.
– Cell medium had a higher impact on the ALP activity compared to the
added biomolecules.
• The hMSCs were cultured on a bilayer consisting of NDs, which were con-
jugated to the BMP-2 derived peptide, and PLL.
– The hMSCs exhibited an increased ALP activity in osteogenic medium
compared to cells cultured in growth medium on plain Ti substrates.
– ALP activity decreased with the increasing number of functional surface
groups of NDs.
• ND-PDDA multilayers on silica glass revealed high biocompatibility.
– The hFOBs presented high cell viability and cell proliferation, respec-
tively.
– The hFOBs showed a significantly higher number of focal adhesions
compared to silica glass without FN coating, which was deduced from
the amount of expressed vinculin.
– Cell area and cell density of hFOBs are comparable to cells cultured on
silica glass substrates with FN coating.
• The number of applied NDs and PDDA bilayers influenced the filopodia
formation of hFOBs and the nanotopography of the substrate.
– A high number of filopodia on smooth surfaces (Rq = 25 ± 5 nm)
compared to rough surfaces (Rq = 43 ± 4 nm) are evident.
– The influence of the nanotopography on the number of focal adhesions
and the viability of hFOBs is non-significant.
• Overall, ND-PDDA multilayers are a biocompatible material applicable in
various biomedical challenges.

7 Summary and Outlook
Detonation nanodiamonds (NDs) are a novel class of carbon-based nanoma-
terials and have recently received a great deal of attention in biomedical ap-
plications due to their high biocompatibility, facile surface modification, and
scalable production. In order to deploy NDs in nanomedicine and drug delivery
applications, fundamental understanding of their surface chemistry and their
drug loading capacity is highly desirable. Accordingly, ND-enhanced coatings of
biomaterials are a promising pathway to develop drug-eluting coatings and to
influence cell fate.
The present thesis describes the transformation from ND suspensions with a
broad agglomerate size distribution into homogeneous and nanostructured ND
coatings, which apply to various materials and surfaces. ND suspensions have
been used in numerous techniques to coat commercially available substrates of
commercially pure grade 4 Ti, Si, silica glass, and polystyrene. Scanning elec-
tron microscopy (SEM) imaging and nanoindentation exhibit the densest and
most strong adhered NDs via 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
and N-hydroxysuccinimide (EDC/NHS)-mediated coupling to silanized surfaces
compared to NDs, which were immobilized via dip coating or electrophoretic de-
position. Furthermore, NDs have been immobilized using polyelectrolyte multi-
layers. The height, which was determined via atomic force microscopy (AFM),
differs from a minimum of 10 nm for one bilayer to a maximum of 90 nm for five
bilayers of NDs and the cationic polyelectrolyte, named polydiallyldimethylam-
monium chloride (PDDA). The colloidal stability of ND suspensions has been
determined using dynamic light scattering in combination with transmission
electron microscopy (TEM). Additionally, a correlated stability model of ND sus-
pensions at different pH has been introduced.
The surface of NDs has been modified via physisorption and chemisorption.
Herein, the bone morphogenetic protein 2 (BMP-2) derived peptide with the
sequence KIPKASSVPTELSAISTLYLGGC (molecular weight = 2336 g/mol) has
been successfully grafted onto NDs using a carboxyl-reactive crosslinking ap-
proach. Initially, functional surface groups of wet- and dry-oxidized NDs were
compared using infrared and mass spectroscopy. Dry-oxidized NDs exhibit the
highest number of carboxylic acid derivatives after air annealing at 415 °C for
5 h. The dry oxidation process led to a 1.4-fold increased number of carbonyl
compounds on NDs compared to wet oxidation. Crosslinking of the carboxylic
acid derivatives on NDs to the primary amines of the BMP-2 derived peptide is
feasible in the range of 30-96% total surface coverage. The ratios of 1:1 and 5:1
ND-peptide were utilized to study the surface loading of NDs using fluorescence
spectroscopy. The chemisorption of BMP-2 derived peptide onto NDs reveals
superior surface coverage and results in reproducible numbers of tethered bio-
molecules.
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The biological performance of the BMP-2 derived peptide, its native protein,
and the related peptide-conjugate NDs has been assessed in vitro. The alka-
line phosphatase (ALP) activity of human mesenchymal stem cells (hMSCs) re-
mained mostly unaffected by the biomolecules, while the influence of the cell
medium seems to play a more dominant role. The high biocompatibility of
ND-PDDA multilayers is essential for their biomedical application. Accordingly,
human fetal osteoblasts (hFOBs) were cultured on ND-PDDA multilayers to as-
sess their application in bone implants. The hFOBs showed a large number of
focal adhesion complexes deduced from quantitative fluorescence imaging anal-
ysis. The influence of the respective surface roughness on filopodia formation
has been assessed, where the rough surface of five bilayers strongly affected the
filopodia formation. The hFOBs grown on NDs tend to show increased cell via-
bility by about 40% and a similar cell morphology compared to cells cultured on
extracellular matrix protein-coated substrates. The high biocompatibility of the
ND-PDDA multilayers and the possibility to control the ND yield on macroscopic
surfaces combined with their drug binding affinity indicates their potential for
drug-eluting coatings and biomaterials in general.
Based on the findings of this study, several research aspects deserve closer
attention. Figure 7.1 depicts the medium-term targets of future ND studies, for
example, as multimodal drug carriers, contrast agents in biomedical imaging,
and additives in polymer coatings. The ND surface can be altered to add ad-
ditional functionalities, such as sensor abilities and biomolecule release due to
an external stimulus. The photoluminescence of NDs can be utilized for in vitro
and in vivo applications. Furthermore, NDs may be incorporated into polymer
coatings using electropolymerization and into metal coatings via anodization
or electroplating. The release kinetics of NDs have to be analyzed in future
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Figure 7.1: Roadmap to transfer NDs into biomedical applications.
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investigations to determine the biomolecule concentration at any given time.
Hereafter, the most important aspects should be considered:
• Various temperature-time regimes and different atmospheres may lead to
an optimized number of carbonyl compounds on the ND surface.
• Covalent attachment strategies are a potential pathway to increase the
number of biomolecules, such as antibiotics and anticancer peptides, on
the ND surface.
• (Bio-)molecules can be released from the ND surface via external stimuli
due to the application of specific linkers.
• Multimodal surface modifications increase the functionality of NDs within
a combinatorial product and reduce the risk of probable side effects.
• The reliability and precision of the obtained ND surface loading can be en-
hanced using a direct detection method such as X-ray photoelectron spec-
troscopy and nuclear magnetic resonance spectroscopy.
• Smaller grinding media decrease the ND agglomerate size and ultimately
increase the available ND surface.
• The investigation related to the influence of the ND concentration on col-
loidal stability can help to decrease the ND agglomerate size.
• The combination of electrophoretic deposition and silanized substrates can
lead to a more uniform ND distribution on macroscopic surfaces.
• The investigation concerning the release kinetics of biofunctional NDs from
polyelectrolyte multilayers will help to control the final layer thickness with
respect to the course of the target disease.
• The application of different polyelectrolytes such as poly-L-lysine (PLL),
poly-L-glutamic acid (PGA), and chitosan can improve the overall biocom-
patibility.
• The electropolymerization of biodegradable polymers, together with bio-
functional NDs, are alternative systems capable of drug release.
• In order to assess the differentiation of mesenchymal stem cells, further
osteogenic markers have to be considered. The significance of the study
can be advanced using an increased number of cell donators.
• Research on hierarchical ND structures and aligned ND patterns enable
detailed insights into the cell-material interactions.
• The assessment of cell viability for durations over 24+ hours helps to ex-
amine the time-depended in vitro cytotoxicity of NDs.
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• Subcutaneous and intramuscular implantation of biomaterials with ND coat-
ings advances the understanding of their in vivo cytotoxicity.
• Studies related to the biodistribution and clearance of NDs in vivo support
their future application in humans.
• Investigations concerning the sterilization of ND coatings promote their
usage in biomedical applications.
• The intrinsic photoluminescence properties of NDs facilitate their long-term
tracking in vitro and encourage the research on the cellular uptake of NDs.
NDs can be implemented in future applications according to the described in-
vestigations. The functionalization of NDs holds numerous scientific challenges,
especially concerning their multimodal surface modification and their drug de-
livery via external stimuli. Further in vitro and in vivo studies of NDs and
ND-enhanced coatings will demonstrate their preclinical and prospective clin-
ical potential. The optimization of the ND coating technique allows for their
widespread industrial application. In summary, NDs are a promising material
with a unique combination of properties and can be utilized in biomedical ap-
plications as well as in medical devices.
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E. Ōsawa. Preparation and behavior of brownish, clear nanodiamond
colloids. Advanced Materials, 19(9):1201–1206, 2007. doi:10.1002/
adma.200601452.
[193] O.A. Shenderova, S. Hens, and G. McGuire. Seeding slurries based on
detonation nanodiamond in DMSO. Diamond and Related Materials, 19(2-
3):260–267, 2010. doi:10.1016/j.diamond.2009.10.008.
[194] N. Gibson, O.A. Shenderova, T.J.M. Luo, S. Moseenkov, V. Bondar,
A. Puzyr, K. Purtov, Z. Fitzgerald, and D.W. Brenner. Colloidal stabil-
ity of modified nanodiamond particles. Diamond and Related Materials,
18(4):620–626, 2009. doi:10.1016/j.diamond.2008.10.049.
[195] J.Y. Raty, G. Galli, C. Bostedt, T.W. Van Buuren, and L.J. Terminello.
Quantum confinement and fullerenelike surface reconstructions in nano-
diamonds. Physical Review Letters, 90(3):037401, 2003. doi:10.1103/
PhysRevLett.90.037401.
[196] J.Y. Raty and G. Galli. Ultradispersity of diamond at the nanoscale. Nature
Materials, 2(12):792–795, 2003. doi:10.1038/nmat1018.
[197] V. Pichot, B. Risse, F. Schnell, J. Mory, and D. Spitzer. Understanding
ultrafine nanodiamond formation using nanostructured explosives. Sci-
entific Reports, 3:2159, 2013. doi:10.1038/srep02159.
[198] R.M. Teeling-Smith, Y.W. Jung, N. Scozzaro, J. Cardellino, I. Rampersaud,
J.A. North, M. Šimon, V.P. Bhallamudi, A. Rampersaud, E. Johnston-
Halperin, M.G. Poirier, and P.C. Hammel. Electron paramagnetic reso-
nance of a single NV nanodiamond attached to an individual biomole-
cule. Biophysical Journal, 110(9):2044–2052, 2016. doi:10.1016/j.
bpj.2016.03.022.
[199] A. Shavel, N. Gaponik, and A. Eychmüller. Covalent linking of
CdTe nanocrystals to amino-functionalized surfaces. ChemPhysChem,
6(3):449–451, 2005. doi:10.1002/cphc.200400516.
96 References
[200] S.L. Goertzen, K.D. Thériault, A.M. Oickle, A.C. Tarasuk, and H.A. An-
dreas. Standardization of the Boehm titration. Part I. CO2 expulsion
and endpoint determination. Carbon, 48(4):1252–1261, 2010. doi:
10.1016/j.carbon.2009.11.050.
[201] C.A. Schneider, W.S. Rasband, and K.W. Eliceiri. NIH Image to ImageJ:
25 years of image analysis. Nature Methods, 9(7):671–675, 2012. doi:
10.1038/nmeth.2089.
[202] M.P. Lake and L.-S. Bouchard. Targeted nanodiamonds for identifica-
tion of subcellular protein assemblies in mammalian cells. PloS One,
12(6):e0179295, 2017. doi:10.1371/journal.pone.0179295.
[203] S. Iimura, K. Manabe, and S. Kobayashi. Direct thioesterification from
carboxylic acids and thiols catalyzed by a brønsted acid. Chemical Com-
munications, (1):94–95, 2002. doi:10.1039/B109834A.
[204] G.T. Hermanson. Bioconjugate Techniques. Elsevier Science, 2013. doi:
10.1016/C2009-0-64240-9.
[205] P. Song, Y. Yu, Q. Wu, and S. Fu. Facile fabrication of HDPE-
g-MA/nanodiamond nanocomposites via one-step reactive blending.
Nanoscale Research Letters, 7(1):355–362, 2012. doi:10.1186/
1556-276X-7-355.
[206] J.P.L. Gonçalves, A.Q. Shaikh, M. Reitzig, D.A. Kovalenko, J. Michael,
R. Beutner, G. Cuniberti, D. Scharnweber, and J. Opitz. Detonation nano-
diamonds biofunctionalization and immobilization to titanium alloy sur-
faces as first steps towards medical application. Beilstein Journal of Or-
ganic Chemistry, 10(1):2765–2773, 2014. doi:10.3762/bjoc.10.293.
[207] P.H. Chung, E. Perevedentseva, J.S. Tu, C.C. Chang, and C.L. Cheng.
Spectroscopic study of bio-functionalized nanodiamonds. Diamond and
Related Materials, 15(4-8):622–625, 2006. doi:10.1016/j.diamond.
2005.11.019.
[208] S. Sotoma, K. Akagi, S. Hosokawa, R. Igarashi, H. Tochio, Y. Harada, and
M. Shirakawa. Comprehensive and quantitative analysis for controlling
the physical/chemical states and particle properties of nanodiamonds for
biological applications. RSC Advances, 5(18):13818–13827, 2015. doi:
10.1039/C4RA16482B.
[209] A.T. Dideikin, A.E. Aleksenskii, M.V. Baidakova, P.N. Brunkov,
M. Brzhezinskaya, V.Y. Davydov, V.S. Levitskii, S.V. Kidalov, Y.A. Kukushk-
ina, D.A. Kirilenko, V.V. Shnitov, A.V. Shvidchenko, B.V. Senkovskiy, M.S.
Shestakov, and A.Y. Vul’. Rehybridization of carbon on facets of detona-
tion diamond nanocrystals and forming hydrosols of individual particles.
Carbon, 122:737–745, 2017. doi:10.1016/j.carbon.2017.07.013.
References 97
[210] S. Osswald, G. Yushin, V. Mochalin, S.O. Kucheyev, and Y. Gogotsi. Con-
trol of sp2/sp3 carbon ratio and surface chemistry of nanodiamond pow-
ders by selective oxidation in air. Journal of the American Chemical Soci-
ety, 128(35):11635–11642, 2006. doi:10.1021/ja063303n.
[211] L. Schmidlin, V. Pichot, M. Comet, S. Josset, P. Rabu, and D. Spitzer. Iden-
tification, quantification and modification of detonation nanodiamond
functional groups. Diamond and Related Materials, 22:113–117, 2012.
doi:10.1016/j.diamond.2011.12.009.
[212] V. Gold. The hydrolysis of acetic anhydride. Transactions of the Faraday
Society, 44:506–518, 1948. doi:10.1039/TF9484400506.
[213] A.N. Ozerin, T.S. Kurkin, L.A. Ozerina, and V.Y. Dolmatov. X-ray diffrac-
tion study of the structure of detonation nanodiamonds. Crystallography
Reports, 53(1):60–67, 2008. doi:10.1134/S1063774508010070.
[214] Q. Zou, M.Z. Wang, and Y.G. Li. Analysis of the nanodiamond particle
fabricated by detonation. Journal of Experimental Nanoscience, 5(4):319–
328, 2010. doi:10.1080/17458080903531021.
[215] H. Tang, M. Wang, D. He, Q. Zou, Y. Ke, and Y. Zhao. Synthesis of nano-
polycrystalline diamond in proximity to industrial conditions. Carbon,
108:1–6, 2016. doi:10.1016/j.carbon.2016.07.004.
[216] A.S. Rajan, S. Sampath, and A.K. Shukla. An in situ carbon-grafted alka-
line iron electrode for iron-based accumulators. Energy & Environmental
Science, 7(3):1110–1116, 2014. doi:10.1039/C3EE42783H.
[217] N.D. Charisiou, S.L. Douvartzides, G.I. Siakavelas, L. Tzounis, V. Sebas-
tian, V. Stolojan, S.J. Hinder, M.A. Baker, K. Polychronopoulou, and M.A.
Goula. The relationship between reaction temperature and carbon de-
position on nickel catalysts based on Al2O3, ZrO2 or SiO2 supports dur-
ing the biogas dry reforming reaction. Catalysts, 9(8):676–698, 2019.
doi:10.3390/catal9080676.
[218] F. Cataldo. A study on the thermal stability to 1000 °C of various car-
bon allotropes and carbonaceous matter both under nitrogen and in air.
Fullerenes, Nanotubes and Carbon Nanostructures, 10(4):293–311, 2002.
doi:10.1081/FST-120016451.
[219] Y.L. Liu and K.W. Sun. Protein functionalized nanodiamond arrays.
Nanoscale Research Letters, 5(6):1045–1050, 2010. doi:10.1007/
s11671-010-9600-7.
[220] L. Guerrini, R.A. Alvarez-Puebla, and N. Pazos-Perez. Surface modi-
fications of nanoparticles for stability in biological fluids. Materials,
11(7):1154, 2018. doi:10.3390/ma11071154.
[221] J. Kong and S. Yu. Fourier transform infrared spectroscopic analysis
of protein secondary structures. Acta Biochimica et Biophysica Sinica,
39(8):549–559, 2007. doi:10.1111/j.1745-7270.2007.00320.x.
98 References
[222] A. Barth. Infrared spectroscopy of proteins. Biochimica et Biophysica
Acta (BBA)-Bioenergetics, 1767(9):1073–1101, 2007. doi:10.1016/j.
bbabio.2007.06.004.
[223] C. Backes, D. Hanlon, B.M. Szydlowska, A. Harvey, R.J. Smith, T.M. Hig-
gins, and J.N. Coleman. Preparation of liquid-exfoliated transition metal
dichalcogenide nanosheets with controlled size and thickness: a state of
the art protocol. Journal of Visualized Experiments, (118):e54806, 2016.
doi:10.3791/54806.
[224] Y. Zhou, C. He, K. Chen, J. Ni, Y. Cai, X. Guo, and X.Y. Wu. A new method
for evaluating actual drug release kinetics of nanoparticles inside dialy-
sis devices via numerical deconvolution. Journal of Controlled Release,
243:11–20, 2016. doi:10.1016/j.jconrel.2016.09.031.
[225] A.R. Studart, E. Amstad, and L.J. Gauckler. Colloidal stabilization of
nanoparticles in concentrated suspensions. Langmuir, 23(3):1081–1090,
2007. doi:10.1021/la062042s.
[226] C.J. Moore, H. Monton, R. O’Kennedy, D.E. Williams, C. Nogues, C. Crean,
and V. Gubala. Controlling colloidal stability of silica nanoparticles dur-
ing bioconjugation reactions with proteins and improving their longer-
term stability, handling and storage. Journal of Materials Chemistry B,
3(10):2043–2055, 2015. doi:10.1039/C4TB01915F.
[227] S. Perveen, N. Safdar, G. Chaudhry, and A. Yasmin. Antibacterial eval-
uation of silver nanoparticles synthesized from lychee peel: individual
versus antibiotic conjugated effects. World Journal of Microbiology and
Biotechnology, 34(8):118, 2018. doi:10.1007/s11274-018-2500-1.
[228] M. Jamal, W. Ahmad, S. Andleeb, F. Jalil, M. Imran, M.A. Nawaz, T. Hus-
sain, M. Ali, M. Rafiq, and M.A. Kamil. Bacterial biofilm and associated
infections. Journal of the Chinese Medical Association, 81(1):7–11, 2018.
doi:10.1016/j.jcma.2017.07.012.
[229] R.M. Donlan. Biofilm formation: a clinically relevant microbiologi-
cal process. Clinical Infectious Diseases, 33(8):1387–1392, 2001. doi:
10.1086/322972.
[230] C. Adlhart, J. Verran, N.F. Azevedo, H. Olmez, M.M. Keinänen-Toivola,
I. Gouveia, L.F. Melo, and F. Crijns. Surface modifications for antimicro-
bial effects in the healthcare setting: A critical overview. Journal of Hospi-
tal Infection, 99(3):239–249, 2018. doi:10.1016/j.jhin.2018.01.018.
[231] A. Elbourne, R.J. Crawford, and E.P. Ivanova. Nano-structured antimi-
crobial surfaces: From nature to synthetic analogues. Journal of Colloid
and Interface Science, 508:603–616, 2017. doi:10.1016/j.jcis.2017.
07.021.
[232] B. Ali, S. Amin, J. Ahmad, A. Ali, M. Ali, and S.R. Mir. Bioavailability
enhancement studies of amoxicillin with nigella. The Indian Journal of
References 99
Medical Research, 135(4):555–559, 2012. URL: http://www.ijmr.org.in/
text.asp?2012/135/4/555/96760.
[233] A. Abraha, A. Kebede, and A. Belay. Study of the self-association of amox-
icillin, thiamine and the hetero-association with biologically active com-
pound chlorgenic acid. African Journal of Pharmacy and Pharmacology,
10(18):393–402, 2016. doi:10.5897/AJPP2016.4542.
[234] A.R. Rote, P.A. Kumbhoje, and R.S. Bhambar. UV-visible spectropho-
tometric simultaneous estimation of paracetamol and nabumetone by
AUC method in combined tablet dosage form. Pharmaceutical Methods,
3(1):40–43, 2012. doi:10.4103/2229-4708.97722.
[235] Á. Jerzsele and G. Nagy. The stability of amoxicillin trihydrate and potas-
sium clavulanate combination in aqueous solutions. Acta Veterinaria Hun-
garica, 57(4):485–493, 2009. doi:10.1556/AVet.57.2009.4.3.
[236] J.M. Andrews. Determination of minimum inhibitory concentrations.
Journal of Antimicrobial Chemotherapy, 48:5–16, 2001. doi:10.1093/
jac/48.suppl_1.5.
[237] T. Wang, S. Handschuh-Wang, P. Qin, Y. Yang, X. Zhou, and Y. Tang.
Enhancing the colloidal stability of detonation synthesized diamond par-
ticles in aqueous solutions by adsorbing organic mono-, bi-and tridentate
molecules. Journal of Colloid and Interface Science, 499:102–109, 2017.
doi:10.1016/j.jcis.2017.03.065.
[238] P. Reineck, D.W.M. Lau, E.R. Wilson, N. Nunn, O.A. Shenderova, and B.C.
Gibson. Visible to near-IR fluorescence from single-digit detonation nano-
diamonds: excitation wavelength and ph dependence. Scientific Reports,
8(1):2478, 2018. doi:10.1038/s41598-018-20905-0.
[239] J. Whitlow, S. Pacelli, and A. Paul. Multifunctional nanodiamonds in
regenerative medicine: recent advances and future directions. Journal of
Controlled Release, 261:62–86, 2017. doi:10.1016/j.jconrel.2017.05.
033.
[240] D.G. Lim, K.H. Kim, E. Kang, S.H. Lim, J. Ricci, S.K. Sung, M.T. Kwon,
and S.H. Jeong. Comprehensive evaluation of carboxylated nanodiamond
as a topical drug delivery system. International Journal of Nanomedicine,
11:2381–2395, 2016. doi:10.2147/IJN.S104859.
[241] A.M.E. Badawy, T.P. Luxton, R.G. Silva, K.G. Scheckel, M.T. Suidan,
and T.M. Tolaymat. Impact of environmental conditions (pH, ionic
strength, and electrolyte type) on the surface charge and aggregation
of silver nanoparticles suspensions. Environmental Science & Technology,
44(4):1260–1266, 2010. doi:10.1021/es902240k.
[242] T.L. Constantopoulos, G.S. Jackson, and C.G. Enke. Effects of salt concen-
tration on analyte response using electrospray ionization mass spectrom-
etry. Journal of the American Society for Mass Spectrometry, 10(7):625–
634, 1999. doi:10.1016/S1044-0305(99)00031-8.
100 References
[243] A. Thalhammer, R.J. Edgington, L.A. Cingolani, R. Schoepfer, and R.B.
Jackman. The use of nanodiamond monolayer coatings to promote the
formation of functional neuronal networks. Biomaterials, 31(8):2097–
2104, 2010. doi:10.1016/j.biomaterials.2009.11.109.
[244] M. Zou, L. Cai, and D. Yang. Nanotribology of a silica nanoparticle-
textured surface. Tribology Transactions, 49(1):66–71, 2006. doi:
10.1080/05698190500486373.
[245] S. Oras, S. Vlassov, M. Berholts, R. Lõhmus, and K. Mougin. Tuning ad-
hesion forces between functionalized gold colloidal nanoparticles and sil-
icon AFM tips: role of ligands and capillary forces. Beilstein Journal of
Nanotechnology, 9(1):660–670, 2018. doi:10.3762/bjnano.9.61.
[246] D. Maharaj and B. Bhushan. Nanomanipulation, nanotribology and
nanomechanics of Au nanorods in dry and liquid environments using
an AFM and depth sensing nanoindenter. Nanoscale, 6(11):5838–5852,
2014. doi:10.1039/C3NR06646K.
[247] Y. Yuk, J.W. Hong, H. Lee, S.W. Han, and J.Y. Park. Shape-dependent
adhesion and friction of Au nanoparticles probed with atomic force
microscopy. Nanotechnology, 26(13):135707, 2015. doi:10.1088/
0957-4484/26/13/135707.
[248] C. Strobel, N. Bormann, A. Kadow-Romacker, G. Schmidmaier, and
B. Wildemann. Sequential release kinetics of two (gentamicin and
BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-
component polymeric coating on implants. Journal of Controlled Release,
156(1):37–45, 2011. doi:10.1016/j.jconrel.2011.07.006.
[249] J.E. Puskas, L.G. Muñoz-Robledo, R.A. Hoerr, J. Foley, S.P. Schmidt,
M. Evancho-Chapman, J. Dong, C. Frethem, and G. Haugstad. Drug-
eluting stent coatings. WIREs Nanomedicine and Nanobiotechnology,
1(4):451–462, 2009. doi:10.1002/wnan.38.
[250] K.E. Uhrich, S.M. Cannizzaro, R.S. Langer, and K.M. Shakesheff.
Polymeric systems for controlled drug release. Chemical Reviews,
99(11):3181–3198, 1999. doi:10.1021/cr940351u.
[251] B.M. Wohl and J.F.J. Engbersen. Responsive layer-by-layer materials for
drug delivery. Journal of Controlled Release, 158(1):2–14, 2012. doi:
10.1016/j.jconrel.2011.08.035.
[252] M.C. Berg, L. Zhai, R.E. Cohen, and M.F. Rubner. Controlled drug release
from porous polyelectrolyte multilayers. Biomacromolecules, 7(1):357–
364, 2006. doi:10.1021/bm050174e.
[253] J. Huang, R. Ma, Y. Ebina, K. Fukuda, K. Takada, and T. Sasaki. Layer-
by-layer assembly of TaO3 nanosheet/polycation composite nanostruc-
tures: Multilayer film, hollow sphere, and its photocatalytic activity for
hydrogen evolution. Chemistry of Materials, 22(8):2582–2587, 2010.
doi:10.1021/cm903733s.
References 101
[254] M. Müller, T. Rieser, P.L. Dubin, and K. Lunkwitz. Selective interaction be-
tween proteins and the outermost surface of polyelectrolyte multilayers:
influence of the polyanion type, pH and salt. Macromolecular Rapid Com-
munications, 22(6):390–395, 2001. doi:10.1002/1521-3927(20010301)
22:6<390::AID-MARC390>3.0.CO;2-B.
[255] A. Schneider, C. Vodouhê, L. Richert, G. Francius, E. Le Guen, P. Schaaf,
J.C. Voegel, B. Frisch, and C. Picart. Multifunctional polyelectrolyte
multilayer films: combining mechanical resistance, biodegradability, and
bioactivity. Biomacromolecules, 8(1):139–145, 2007. doi:10.1021/
bm060765k.
[256] A. Dierich, E. Le Guen, N. Messaddeq, J.F. Stoltz, P. Netter, P. Schaaf, J.C.
Voegel, and N. Benkirane-Jessel. Bone formation mediated by synergy-
acting growth factors embedded in a polyelectrolyte multilayer film. Ad-
vanced Materials, 19(5):693–697, 2007. doi:10.1002/adma.200601271.
[257] L. Moore, M. Gatica, H. Kim, E. Ōsawa, and D. Ho. Multi-protein delivery
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Appendix
Appendix: List of all reagents and materials employed in the present thesis.
Reagent / Material Supplier
(3-Aminopropyl)triethoxysilane, purity > 98.00% Merck KGaA, Darmstadt,
Germany
β-Glycerophosphate, purity > 99.00% Merck KGaA, Darmstadt,
Germany
1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide,
residue < 0.1%
Carl Roth GmbH Co. KG,
Karlsruhe, Germany
2-(N-Morpholino)ethanesulfonic acid,
purity > 99.00%
Merck KGaA, Darmstadt,
Germany
2-Mercaptoethanol, purity > 99.00% Merck KGaA, Darmstadt,
Germany
2-Phospho-L-ascorbic acid trisodium salt,
purity > 95.00%
Merck KGaA, Darmstadt,
Germany
4’,6-Diamidino-2-phenylindole, purity > 98.00% Vector Laboratories Inc.,
Burlingame, CA, USA
Absolute ethanol, purity > 99.50% Merck KGaA, Darmstadt,
Germany
Acetone, purity > 99.50% Carl Roth GmbH Co. KG,
Karlsruhe, Germany
Alexa Fluor™ 633 Phalloidin Thermo Fisher Scientific,
Waltham, MA, USA
Alexa Fluor™ 488 Thermo Fisher Scientific,
Waltham, MA, USA
Alkaline phosphatase yellow liquid substrate Merck KGaA, Darmstadt,
Germany
Amoxicillin, potency > 900 µg per mg Merck KGaA, Darmstadt,
Germany
Bone morphogenetic protein-2 derived peptide,
KIPKASSVPTELSAISTLYLGGC
Biotrend Chemikalien GmbH,
Köln, Germany
Bovine serum albumin, purity > 98.00% Merck KGaA, Darmstadt,
Germany
Commercially pure grade 4 titanium, 16 mm in
diameter and 1.5 mm thick, mirror-polished
DOT medical implant solutions
GmbH, Rostock, Germany
Detonation nanodiamonds (PL-D-G01) PlasmaChem GmbH, Berlin,
Germany
Dexamethasone, purity > 97.00% Merck KGaA, Darmstadt,
Germany
Dimethyl sulfoxide, purity > 99.70% Merck KGaA, Darmstadt,
Germany
Dulbecco’s Modified Eagle’s Medium Thermo Fisher Scientific,
Waltham, MA, USA
Ethanol denatured, purity > 96.00% Carl Roth GmbH Co. KG,
Karlsruhe, Germany
Fetal Bovine Serum Merck KGaA, Darmstadt,
Germany
Fibronectin, human plasma Merck KGaA, Darmstadt,
Germany
H2O2 solution, c = 30% (w/w) Merck KGaA, Darmstadt,
Germany
H2SO4 solution, c = 95% (w/w) Merck KGaA, Darmstadt,
Germany
HCl aqueous solution, c = 35% (w/w) Merck KGaA, Darmstadt,
Germany
HNO3 solution, c = 35% (w/w) Merck KGaA, Darmstadt,
Germany
KBr (FT-IR grade), purity > 99.00% Merck KGaA, Darmstadt,
Germany
NaCl, purity > 99.00% Merck KGaA, Darmstadt,
Germany
NaHCO3, purity > 99.70% Merck KGaA, Darmstadt,
Germany
NaOH pellets, purity > 97.00% Merck KGaA, Darmstadt,
Germany
N-Hydroxysuccinimide, purity > 98.00% Merck KGaA, Darmstadt,
Germany
Paraformaldehyde Merck KGaA, Darmstadt,
Germany
Penicillin-Streptomycin Thermo Fisher Scientific,
Waltham, MA, USA
Phosphate buffered saline Merck KGaA, Darmstadt,
Germany
p-Nitrophenyl phosphate Carl Roth GmbH Co. KG,
Karlsruhe, Germany
Polydiallyldimethylammonium chloride solution,
c = 20 wt% in H2O
Merck KGaA, Darmstadt,
Germany
Poly-L-lysine hydrobromide (MW 30000-70000
g/mol)
Merck KGaA, Darmstadt,
Germany
Silica glass microscope slides Corning Korea Company Ltd.,
Seoul, Republic of Korea
Triton™X-100, synonym for
4-(1,1,3,3-tetramethylbutyl)phenyl-polyethylene
glycol solution
Merck KGaA, Darmstadt,
Germany
Vinculin primary antibody Merck KGaA, Darmstadt,
Germany
Vybrant® MTT cell proliferation assay kit Thermo Fisher Scientific,
Waltham, MA, USA
Yttrium-stabilized ZrO2 microbeads (SiLibeads®
Ceramic Beads Type ZY-P)
Sigmund Lindner GmbH,
Warmensteinach, Germany

List of Publications
Peer-reviewed publications.
No. Publication
[1] S. Balakin, Y.-S. Yun, J. Lee, E.-H. Kang, J. Spohn, I.-S. Yun, J.
Opitz, G. Cuniberti, J.-S. Yeo. In vitro characterization of
osteoblast cells on polyelectrolyte multilayers containing
detonation nanodiamonds. Biomedical Materials in press, 2020.
doi: 10.1088/1748-605X/ab9baf.
[2] E. Krok, S. Balakin, J. Jung, F. Gross, J. Opitz, G. Cuniberti.
Modification of titanium implants using biofunctional
nanodiamonds for enhanced antimicrobial properties.
Nanotechnology, 31(20):205603, 2020. doi:
10.1088/1361-6528/ab6d9b.
[3] S. Balakin, A. Missirlis, B. Klemmed, J. Lee, J. Opitz, J.-S. Yeo, G.
Cuniberti. Quantitative analysis of BMP-2 derived peptide
covalently grafted onto oxidized detonation nanodiamonds.
Carbon, 152:740–745, 2019. doi:
10.1016/j.carbon.2019.05.064.
[4] S. Balakin, N.R. Dennison, B. Klemmed, J. Spohn, G. Cuniberti,
L. Röhmhildt, J. Opitz. Immobilization of Detonation
Nanodiamonds on Macroscopic Surfaces. Applied Sciences,
9(6):1064–1076, 2019. doi: 10.3390/app9061064.
[5] B. Sarac, S. Bera, F. Spieckermann, S. Balakin, M. Stoica, M.
Calin, J. Eckert. Micropatterning kinetics of different
glass-forming systems investigated by thermoplastic net-shaping.
Scripta Materialia, 137:127–131, 2017. doi:
10.1016/j.scriptamat.2017.02.038.
[6] B. Sarac, S. Bera, S. Balakin, M. Stoica, M. Calin, J. Eckert.
Hierarchical surface patterning of Ni-and Be-free Ti-and Zr-based
bulk metallic glasses by thermoplastic net-shaping. Materials
Science and Engineering: C, 73:398–405, 2017. doi:
10.1016/j.msec.2016.12.059.
[7] S. Bera, B. Sarac, S. Balakin, P. Ramasamy, M. Stoica, M. Calin,
J. Eckert. Micro-patterning by thermoplastic forming of Ni-free
Ti-based bulk metallic glasses. Materials & Design, 120:204–211,
2017. doi: 10.1016/j.matdes.2017.01.080.
Issued patents.
No. Patent
[1] S. Balakin, J. Opitz, inventors. Coating for implantable medical
devices, method for producing same, and implantable medical
device. World patent WO/2020/011486. 2020 Jan 16. German.
Retrieved from https://patentscope.wipo.int
Selected international conferences and workshops.
No. Contribution
[1] S. Balakin, A. Missirlis, J. Lee, D. In, L. Römhildt, J. Opitz, G.
Cuniberti, J-S. Yeo. Detonation nanodiamonds as smart coating
materials for biomedical devices. 29th International Conference
on Diamond and Carbon Materials (09/2018). Croatia – Oral
presentation.
[2] S. Balakin, A.Q. Shaikh, A. Missirlis, J. Opitz. Bio-functional
detonation nanodiamonds as smart coating materials –
ND-amoxicillin conjugates & polyelectrolyte based surface
multilayers. European Advanced materials congress (08/2018).
Sweden – Oral presentation.
[3] D. In, S. Balakin, J. Lee, L. Römhildt, J. Opitz, G. Cuniberti, and
J.-S. Yeo. Immobilization of Detonation Nanodiamonds Using
Polyelectrolyte Multilayer Films. Korean Vacuum Society
Conference ‘Nanoscience and Biointerface’ (02/2018). Republic
of Korea – Poster presentation.
[4] S. Balakin, L. Römhildt, J. Opitz, G. Cuniberti. Titanium surface
engineering using detonation nanodiamonds towards biomedical
applications. 18th Trends in Nanotechnology International
Conference (08/2017). Germany – Poster presentation.
[5] S. Balakin, L. Römhildt, J. Opitz, G. Cuniberti. Surface
engineering of Ti-based materials using detonation
nanodiamonds. Workshop Global Research Lab–FYK (08/2016).
Republic of Korea – Oral presentation.


